Candidiasis

AB1_CANDIDIASIS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — B37 Hospital discharge: ICD-9 — 112 Hospital discharge: ICD-8 — 112 Cause of death: ICD-10 — B37 Cause of death: ICD-9 — 112 Cause of death: ICD-8 — 112 2 out of 7 registries used, show all original rules.	5574
4. Check minimum number of events None	5574
5. Include endpoints None	5574
6. Filter based on genotype QC (FinnGen only)	5574

Control definitions (FinnGen only)

Control exclude: AB1_MYCOSES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5

NAME	AB1_CANDIDIASIS
CONTROL_EXCLUDE	AB1_MYCOSES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B37
HD_ICD_9	112
HD_ICD_8	112
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B37
COD_ICD_9	112
COD_ICD_8	112
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Candidiasis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Explicit fungal Sepsis

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	38361	25371	12707
Only index persons	33606	22803	10803
Unadjusted period prevalence (%)
Whole population	0.60	0.73	0.36
Only index persons	0.70	0.84	0.41
Median age at first event (years)
Whole population	43.09	37.41	54.38
Only index persons	41.76	36.25	53.38

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5574	3840	1734
Unadjusted period prevalence (%)	1.14	1.31	0.76
Median age at first event (years)	46.56	40.01	61.04

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4981: Matched controls
49808

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

11299

ICD-8 Finland

Moniliasis

+∞

323.0

500

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

1509.3

323.0

539

B37.08

ICD-10 Finland

Other candidal stomatitis

108.8

323.0

482

B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

35.6

323.0

709

231

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

39.0

323.0

838

257

A07AA02

ATC

nystatin; oral

8.2

323.0

904

1316

J02AC01

ATC

fluconazole; systemic

3.8

323.0

3114

15146

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

63.7

323.0

463

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

6.5

284.9

807

1430

B37.4

ICD-10 Finland

Candidiasis of other urogenital sites

195.1

283.9

294

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.9

236.7

1912

8697

B37.03

ICD-10 Finland

Chronic atrophic candida infection in the mouth

223.5

208.2

214

B37.00

ICD-10 Finland

Acute pseudomembraneuous candidal stomatitis

170.2

202.4

212

B37.2

ICD-10 Finland

Candidiasis of skin and nail

32.9

199.1

265

B37.7

ICD-10 Finland

Candidal sepsis

+∞

197.2

188

SBA00

NOMESCO Finland

Microbiological examinations

10.2

192.4

399

423

B37.8

ICD-10 Finland

Candidiasis of other sites

195.2

181.3

188

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

169.1

2377

13996

H02AB06

ATC

prednisolone; systemic

2.1

139.3

2544

16357

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.2

125.9

1914

11202

A01AB09

ATC

miconazole; local oral

3.4

124.6

672

2175

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

5.6

123.7

385

736

A02BC02

ATC

pantoprazole; systemic

2.1

123.0

3328

24600

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.4

123.0

1275

6209

B37.01

ICD-10 Finland

Acute athrophy candidal stomatitis

120.3

119.6

129

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.1

106.4

663

2366

J45.9

ICD-10 Finland

Asthma, unspecified

2.4

103.0

1055

5041

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.6

102.6

858

3673

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.0

100.8

1638

9629

J01MA12

ATC

levofloxacin; systemic

2.3

97.1

1040

5062

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

95.3

808

3475

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

93.4

1951

12534

N02AX02

ATC

tramadol; systemic, rectal

1.9

89.2

2094

13953

N03AX16

ATC

pregabalin; oral

2.1

88.5

1274

7050

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.5

88.1

789

3484

H02AB04

ATC

methylprednisolone; systemic

2.4

87.8

878

4108

B37.0

ICD-10 Finland

Candidal stomatitis

11.2

84.5

164

151

J01DB01

ATC

cefalexin; oral

2.0

83.1

4091

34637

J01FF01

ATC

clindamycin; systemic

2.0

82.9

1430

8464

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

3.6

82.4

396

1153

C03CA01

ATC

furosemide; systemic

2.0

81.3

1315

7580

J01MA02

ATC

ciprofloxacin; systemic

1.8

80.7

1928

12788

SAA03

NOMESCO Finland

Extended examination of mouth

1.8

80.4

2011

13539

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

6.4

80.4

221

359

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

5.7

80.1

243

447

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

3.9

79.7

351

948

N02AA05

ATC

oxycodone; systemic

2.4

76.7

765

3550

R06.0

ICD-10 Finland

Dyspnoea

2.0

76.1

1270

7379

A02BC05

ATC

esomeprazole; systemic

1.8

74.7

2026

13899

R50.9

ICD-10 Finland

Fever, unspecified

2.3

74.5

782

3719

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

74.5

2074

14343

UJF32

NOMESCO Finland

Coloscopy

1.9

74.2

1307

7735

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.1

73.8

1049

5709

R03BB04

ATC

tiotropium bromide; inhalant

2.7

72.2

541

2144

P01AB01

ATC

metronidazole; oral, rectal

1.7

71.7

2045

14196

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

71.4

931

4877

EKA10

NOMESCO Finland

Biopsy of cheek

6.0

70.6

204

353

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.7

70.4

333

955

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.9

70.2

478

1783

R13

ICD-10 Finland

Dysphagia

3.2

70.0

408

1370

E0000UV

ATC

1.7

69.8

2008

13938

B37.02

ICD-10 Finland

Chronic hyperplastic candidal stomatitis

182.5

69.2

AA1AD

NOMESCO Finland

CT of head and brain

1.9

68.1

1136

6554

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

67.9

944

5066

R03AC02

ATC

salbutamol; inhalant

1.7

67.5

2619

19771

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.5

67.5

580

2479

B37.04

ICD-10 Finland

Skin-mucous candidal stomatitis

40.7

66.8

N76.8

ICD-10 Finland

Other specified inflammation of vagina and vulva

7.1

66.2

168

244

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

66.1

1121

6494

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.2

65.4

363

1177

L43.8

ICD-10 Finland

Other lichen planus

6.1

64.9

183

307

N06AX11

ATC

mirtazapine; oral

1.8

64.9

1600

10525

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

63.8

1106

6448

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

63.7

2528

19077

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

63.6

1594

10522

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.5

63.1

317

953

A01AB04

ATC

amphotericin B; local oral

3.4

62.6

326

1007

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.4

62.6

599

2705

J01MA14

ATC

moxifloxacin; systemic

2.6

62.4

492

1998

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.9

62.4

1173

7031

K13.74

ICD-10 Finland

Lichen rubs planus in the mouth

7.5

62.2

152

209

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.8

62.2

427

1596

H02AB07

ATC

prednisone; oral

2.1

61.7

763

3881

A56.0

ICD-10 Finland

Chlamydial infection of lower genitourinary tract

6.1

61.7

174

292

N76.0

ICD-10 Finland

Acute vaginitis

2.9

61.4

415

1536

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

60.2

875

4756

J05AB01

ATC

aciclovir; systemic

1.9

58.2

1098

6567

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.9

58.1

255

685

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.7

57.9

436

1723

J02AC02

ATC

itraconazole; systemic

1.9

57.7

947

5385

N05BA04

ATC

oxazepam; oral

1.8

57.5

1277

8061

N02BE01

ATC

paracetamol; systemic, rectal

1.8

57.5

4185

36898

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

57.4

689

3454

SAA04

NOMESCO Finland

Special inverstigation of mouth

3.0

57.1

355

1244

A63.0

ICD-10 Finland

Anogenital (venereal) warts

3.4

56.6

291

890

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.1

56.5

716

3669

J45.1

ICD-10 Finland

Nonallergic asthma

2.7

55.9

410

1594

K13.78

ICD-10 Finland

Other change in the oral mucosa

5.1

55.4

181

363

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.5

54.8

203

465

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

54.8

1189

7429

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

54.0

1007

5979

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

54.0

682

3488

A06AD11

ATC

lactulose; oral

2.1

53.7

680

3480

N06AB04

ATC

citalopram; systemic

1.8

53.5

1103

6768

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

52.8

605

2962

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

52.8

646

3256

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

52.6

1172

7370

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

52.5

887

5078

R11

ICD-10 Finland

Nausea and vomiting

2.5

52.3

456

1953

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

52.0

1229

7867

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

51.9

2182

16370

A02BC01

ATC

omeprazole; systemic

1.7

51.8

1339

8803

D07AC01

ATC

betamethasone; topical

1.7

51.7

1610

11162

A02BC03

ATC

lansoprazole; oral

1.7

51.6

1372

9098

R03DC03

ATC

montelukast; oral

1.9

51.5

841

4752

R06AE07

ATC

cetirizine; oral

1.6

51.2

2163

16230

N30.0

ICD-10 Finland

Acute cystitis

2.0

51.0

755

4108

N03AX12

ATC

gabapentin; oral

2.0

50.7

781

4313

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

50.4

570

2770

ZXD05

NOMESCO Finland

Urgent procedure

1.7

50.2

1543

10641

N05AH04

ATC

quetiapine; oral

1.9

50.1

834

4741

A41.9

ICD-10 Finland

Sepsis, unspecified

3.8

49.8

220

594

R53

ICD-10 Finland

Malaise and fatigue

1.8

49.7

1019

6221

127

Kela drug reimbursment

Transplant complication

6.3

49.4

136

222

N05CF01

ATC

zopiclone; oral

1.6

49.4

1522

10493

JN3AD

NOMESCO Finland

Abdominal CT examination

2.5

49.4

407

1689

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.2

49.3

271

870

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

49.2

729

3965

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

49.1

2143

16149

R51.80

ICD-10 Finland

Headache

1.9

49.1

776

4325

L43.9

ICD-10 Finland

Lichen planus, unspecified

5.2

48.9

158

313

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

4.1

48.8

198

495

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

48.7

1281

8435

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

48.0

527

2524

J01DA01

ATC

[U] cefalexin; systemic

1.6

47.8

2991

24503

WX110

NOMESCO Finland

Local anesthesy

1.6

47.7

3280

27472

H04.10

ICD-10 Finland

Dry eye syndrome

2.2

47.5

518

2472

J01FA06

ATC

roxithromycin; oral

1.6

47.1

1935

14319

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

46.8

643

3389

L04AA06

ATC

mycophenolic acid; systemic

5.4

46.7

144

271

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

46.3

551

2734

A60.0

ICD-10 Finland

Herpesviral infection of genitalia and urogenital tract

5.0

46.1

154

317

B37.99

ICD-10 Finland

Candida infection, unspecified

75.2

46.0

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.2

45.9

486

2284

B37.9

ICD-10 Finland

Candidiasis, unspecified

161.5

45.9

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.3

45.1

452

2071

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

44.7

1120

7245

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

44.5

486

2318

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.4

44.5

416

1841

JN4BD

NOMESCO Finland

Extensive body CT

2.1

44.4

533

2653

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.5

44.2

381

1618

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

43.9

509

2494

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.7

43.7

312

1189

TGC00

NOMESCO Finland

Bronchial lavation

4.3

43.6

169

405

A02BA02

ATC

ranitidine; systemic

1.8

43.6

919

5633

UKC02

NOMESCO Finland

Cystoscopy

1.9

43.2

699

3914

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.5

43.2

362

1511

J01AA02

ATC

doxycycline; systemic

1.6

43.1

3674

31927

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

43.1

882

5351

R03BA05

ATC

fluticasone; inhalant

1.8

42.8

904

5540

K13.29

ICD-10 Finland

Indefinite leukoplakia

7.0

42.6

108

158

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

42.5

3346

28471

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.3

42.3

410

1846

A10AE04

ATC

insulin glargine; parenteral

2.2

42.3

452

2131

J01EA01

ATC

trimethoprim; systemic

1.6

42.0

1255

8504

XQ800

NOMESCO Finland

Prick test

2.3

41.9

423

1944

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.1

41.5

516

2601

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

41.4

463

2231

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.3

41.3

220

690

J05AB11

ATC

valaciclovir; oral

1.9

40.9

666

3732

SPAT1254

SPAT

Administration of medicine

1.9

40.7

700

3997

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.8

40.4

284

1071

N06AA09

ATC

amitriptyline; systemic

2.1

40.4

508

2572

Z2446

NOMESCO Finland

Social worker

2.4

40.1

352

1508

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.2

39.8

428

2025

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

39.7

612

3357

H02AB09

ATC

hydrocortisone; systemic

4.1

39.6

161

404

J45

ICD-10 Finland

Asthma

2.1

39.5

508

2598

ECA20

NOMESCO Finland

Biopsy of gingiva

6.4

39.3

106

169

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.1

39.3

464

2289

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.1

39.2

478

2389

E000001

ATC

1.7

39.2

1003

6491

M79.6

ICD-10 Finland

Pain in limb

1.5

38.9

1624

11914

UJF30

NOMESCO Finland

Ileoscopy through colon

2.1

38.5

480

2420

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

38.2

1851

14022

D64.9

ICD-10 Finland

Anaemia, unspecified

2.1

38.2

456

2257

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.7

37.6

276

1070

1121A

ICD-9 Finland

Candidiasis, Of vulva and vagina

+∞

37.5

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

37.4

717

4241

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

6.2

37.4

103

169

WW500

NOMESCO Finland

Blood transfusion

3.0

37.4

232

810

A46

ICD-10 Finland

Erysipelas

1.9

36.9

597

3327

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

36.7

1283

8992

SPAT1262

SPAT

Handing over of treatment supplies

1.7

36.6

812

5027

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.5

36.6

310

1303

A04

ICPC

Weakness/tiredness general

1.9

36.3

625

3562

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.8

36.3

248

919

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.4

36.3

184

557

S18

ICPC

Laceration/cut

1.5

36.2

1824

13889

N51.2*B37.4

ICD-10 Finland

Candidal balanitis

41.2

36.2

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.0

36.1

214

724

R02

ICPC

Shortness of breath/dyspnoea

1.9

36.1

572

3163

JDB10

NOMESCO Finland

Percutaneous gastrostomy

6.1

36.0

100

166

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.9

35.9

152

396

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

35.7

890

5697

WX002

NOMESCO Finland

Sedation and analgesia

1.7

35.6

905

5825

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.7

35.5

251

949

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.3

35.5

187

583

Z3226

NOMESCO Finland

Physiotherapist

1.7

35.4

855

5421

XG410

NOMESCO Finland

Flow-volume spirometry

2.9

35.1

223

789

L04AX01

ATC

azathioprine; systemic

2.7

35.0

256

990

WX892

NOMESCO Finland

Monitored bed care

2.3

34.9

358

1652

JN4AD

NOMESCO Finland

Body CT examination

2.2

34.9

361

1674

D07AD01

ATC

clobetasol; topical

1.8

34.9

728

4415

J01CA04

ATC

amoxicillin; systemic

1.5

34.9

3872

34593

J01FA10

ATC

azithromycin; systemic

1.4

34.9

2739

22776

R03BA02

ATC

budesonide; inhalant

1.7

34.8

845

5361

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.3

34.7

342

1550

R01AD09

ATC

mometasone; nasal

1.5

34.7

2111

16677

K12.10

ICD-10 Finland

Stomatitis NOS

10.3

34.7

SPAT1263

SPAT

Sampling

1.5

34.3

1998

15630

EHA10

NOMESCO Finland

Biopsy of palate

7.9

34.2

101

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.8

34.1

117

249

J46

ICD-10 Finland

Status asthmaticus

3.4

33.5

170

515

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

33.4

1064

7262

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.1

33.1

411

2066

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.7

33.1

242

936

R05

ICD-10 Finland

Cough

1.6

32.9

889

5809

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.8

32.5

222

824

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

32.4

471

2519

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

32.4

1331

9635

N06AX21

ATC

duloxetine; oral

1.9

32.4

535

2998

SBB10

NOMESCO Finland

Teeth copy

2.3

32.3

315

1418

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

32.2

1080

7452

K12.18

ICD-10 Finland

Other forms of stomatitis

7.6

32.1

101

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

32.1

356

1703

L17

ICPC

Foot/toe symptom/complaint

1.6

32.1

1112

7735

Z01.2

ICD-10 Finland

Dental examination

1.4

31.9

1896

14825

L04AD01

ATC

ciclosporin; systemic

4.1

31.9

127

314

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.4

31.8

278

1185

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.8

31.7

213

782

R01AD08

ATC

fluticasone; nasal

1.5

31.6

1325

9629

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.8

31.6

208

755

ZX120

NOMESCO Finland

Intravenous

2.0

31.5

444

2348

TK800

NOMESCO Finland

Hemodialysis

4.1

31.2

125

311

SPF30

NOMESCO Finland

Soling for prothesis

4.2

31.2

122

297

SPAT1255

SPAT

Intravenous administration of medicine

2.3

31.1

317

1457

K11.70

ICD-10 Finland

Hypoptyalism

7.7

31.1

C07AB07

ATC

bisoprolol; oral

1.4

31.1

1908

14991

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.0

31.1

441

2337

GD1AD

NOMESCO Finland

Thorax CT examination

2.7

31.1

223

854

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

31.0

624

3729

J01CA08

ATC

pivmecillinam; oral

1.4

30.8

1973

15620

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.3

30.8

297

1329

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.2

30.8

168

538

K13.20

ICD-10 Finland

Idiopathic leukoplakia

9.4

30.7

R21

ICPC

Throat symptom/complaint

1.6

30.7

957

6478

N06AX16

ATC

venlafaxine; oral

1.7

30.6

676

4161

M54.5

ICD-10 Finland

Low back pain

1.5

30.6

1500

11256

N05CD07

ATC

temazepam; oral

1.8

30.5

546

3142

M79.1

ICD-10 Finland

Myalgia

1.8

30.4

612

3659

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

30.4

965

6559

R03BA01

ATC

beclometasone; inhalant

1.7

30.1

660

4050

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.1

30.1

380

1922

K02.1

ICD-10 Finland

Caries of dentine

1.4

30.0

2586

21596

Z3231

NOMESCO Finland

Registered nurse

1.5

30.0

1196

8574

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.1

30.0

353

1734

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.2

29.9

333

1596

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.8

29.5

100

211

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

2.6

29.4

231

931

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

29.3

955

6526

R03AC12

ATC

salmeterol; inhalant

2.6

29.2

228

914

L28

ICPC

Limited function/disability (L)

1.7

29.2

652

4022

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

29.2

796

5193

J20

ICD-10 Finland

Acute bronchitis

1.9

29.1

456

2503

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.2

29.1

299

1382

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

29.1

2976

25573

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.5

29.0

236

968

R96

ICPC

Asthma

2.0

28.9

418

2228

M01AE02

ATC

naproxen; oral, rectal

1.4

28.9

2591

21735

B37.06

ICD-10 Finland

Candidal cheilitis

44.0

28.7

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

28.6

640

3949

R03BA08

ATC

ciclesonide; inhalant

2.0

28.6

393

2053

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.8

28.5

520

3008

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

28.5

1646

12717

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

28.4

1272

9332

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.0

28.4

375

1931

N05BA01

ATC

diazepam; systemic, rectal

1.7

28.3

593

3585

XW000

NOMESCO Finland

Bone marrow biopsy

2.7

28.3

202

771

S97

ICPC

Chronic ulcer skin

2.5

28.3

233

964

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.9

28.1

179

636

A04AA01

ATC

ondansetron; systemic, rectal

2.1

28.1

323

1568

R42

ICD-10 Finland

Dizziness and giddiness

1.6

28.1

931

6379

N06AB03

ATC

fluoxetine; oral

1.7

28.1

594

3604

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.8

28.0

188

691

Z2221

NOMESCO Finland

Medical doctor

1.5

28.0

1282

9447

GBB00

NOMESCO Finland

Tracheostomy

5.6

28.0

151

A10AE05

ATC

insulin detemir; parenteral

2.3

27.8

259

1141

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

27.8

887

6018

G47.3

ICD-10 Finland

Sleep apnoea

1.6

27.7

832

5556

J37.0

ICD-10 Finland

Chronic laryngitis

2.9

27.7

171

595

R33

ICD-10 Finland

Retention of urine

2.2

27.7

294

1377

R03AC13

ATC

formoterol; inhalant

2.4

27.6

254

1110

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.1

27.6

350

1769

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.3

27.6

144

447

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

27.5

1256

9241

A41.8

ICD-10 Finland

Other specified sepsis

4.6

27.5

214

A03FA02

ATC

cisapride; oral, rectal

2.0

27.3

357

1829

I50.9

ICD-10 Finland

Heart failure, unspecified

1.8

27.3

476

2709

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

27.3

840

5645

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

27.2

594

3635

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.7

27.1

186

694

SXA10

NOMESCO Finland

Epithel biopsy of mouth

4.7

27.0

200

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.0

27.0

371

1940

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

26.9

2176

17825

A02BC04

ATC

rabeprazole; oral

1.9

26.8

395

2120

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

26.8

407

2211

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

4.5

26.8

220

SXC03

NOMESCO Finland

Other oral or dental procedure

5.5

26.8

147

XQ802

NOMESCO Finland

Epicutan test

2.4

26.8

226

948

J01MA06

ATC

norfloxacin; oral

1.7

26.7

628

3928

R03AK08

ATC

formoterol and beclometasone; inhalant

2.6

26.6

196

762

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.2

26.6

269

1235

R51

ICD-10 Finland

Headache

2.2

26.5

268

1230

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.6

26.4

201

797

D07AC13

ATC

mometasone; topical

1.5

26.3

1254

9293

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.9

26.3

167

592

WX872

NOMESCO Finland

Intensive care

2.4

26.3

225

949

K23.8

ICD-10 Finland

Disorders of oesophagus in other diseases classified elsewhere

29.4

26.3

A28

ICPC

Limited function/disability NOS

1.7

26.2

564

3432

G44.2

ICD-10 Finland

Tension-type headache

1.7

26.2

622

3897

SXC05

NOMESCO Finland

Other oral or dental procedure

2.2

26.2

281

1324

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

26.2

1223

9025

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

26.1

705

4579

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

26.1

723

4728

N05AH03

ATC

olanzapine; systemic

2.2

26.0

284

1348

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

25.9

280

1324

WZC30

NOMESCO Finland

Teaching

1.7

25.8

575

3535

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

3.1

25.8

148

491

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.3

25.8

240

1057

M03BX02

ATC

tizanidine; oral

1.4

25.8

2804

24089

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

25.8

1606

12530

N03AG01

ATC

valproic acid; systemic, rectal

2.2

25.7

284

1355

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.9

25.6

376

2016

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.8

25.6

172

632

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.1

25.5

318

1598

D01AC02

ATC

miconazole; topical

2.0

25.5

345

1793

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.8

25.4

472

2742

R4110

NOMESCO Finland

Physiotherapy

1.5

25.4

1114

8105

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

6.3

25.4

109

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.9

25.3

378

2038

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

25.3

653

4187

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

11.0

25.3

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

25.2

417

2331

N05CF02

ATC

zolpidem; oral

1.6

25.1

787

5302

N01

ICPC

Headache

1.8

25.0

472

2761

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

24.9

2377

19929

N77.1

ICD-10 Finland

Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere

4.6

24.8

191

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

24.8

325

1668

R74

ICPC

Upper respiratory infection acute

1.4

24.8

1304

9837

SPAT1301

SPAT

No procedures

1.4

24.7

1404

10750

SPAT1211

SPAT

Application of soft bandage

1.9

24.6

397

2201

XCK10

NOMESCO Finland

Photography of fundus of eye

1.8

24.6

413

2322

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

3.7

24.5

108

294

R60.0

ICD-10 Finland

Localized oedema

1.8

24.5

469

2751

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.4

24.4

219

947

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

24.3

1019

7334

WZA90

NOMESCO Finland

Other doctors statement

1.5

24.3

1002

7190

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.3

24.1

224

987

B37.1

ICD-10 Finland

Pulmonary candidiasis

+∞

24.0

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.8

23.9

422

2410

J01MA01

ATC

ofloxacin; systemic

1.9

23.9

370

2019

T89

ICPC

Diabetes insulin dependent

2.6

23.9

185

740

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.7

23.9

537

3309

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.7

23.8

166

624

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.2

23.8

128

408

SPF20

NOMESCO Finland

Temporary soling for filling

5.6

23.7

127

N48.1

ICD-10 Finland

Balanoposthitis

3.9

23.7

100

262

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.3

23.7

217

948

K59.0

ICD-10 Finland

Constipation

2.2

23.7

246

1142

N30.9

ICD-10 Finland

Cystitis, unspecified

2.1

23.6

270

1309

N06AB10

ATC

escitalopram; oral

1.5

23.5

923

6543

M02AA07

ATC

piroxicam; topical

1.4

23.5

1540

12074

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.8

23.4

458

2705

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.9

23.3

364

1994

C05AA08

ATC

fluocortolone; rectal, topical

1.6

23.2

614

3956

UJD02

NOMESCO Finland

Gastroscopy

2.3

23.1

222

995

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.0

23.0

307

1584

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

5.9

23.0

112

R03AC03

ATC

terbutaline; inhalant

1.6

22.9

628

4085

X58

ICD-10 Finland

Exposure to other specified factors

1.6

22.8

585

3740

D07AA02

ATC

hydrocortisone; topical

1.6

22.8

618

4006

A01AB10

ATC

natamycin; local oral

2.8

22.7

151

551

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

22.7

3162

27979

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.3

22.7

116

356

SXB00

NOMESCO Finland

Removeal of sutres from oral mucosa

2.0

22.7

294

1502

J02AC03

ATC

voriconazole; systemic

40.3

22.6

N03AE01

ATC

clonazepam; systemic

2.1

22.6

267

1312

E000006

ATC

1.9

22.6

342

1852

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.2

22.6

237

1107

K30

ICD-10 Finland

Functional dyspepsia

1.7

22.5

458

2740

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

22.4

1201

9059

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.6

22.4

587

3770

XG466

NOMESCO Finland

Sleep oxymetry

2.8

22.4

147

535

L04AA01

ATC

[U] ciclosporin; systemic

3.9

22.4

241

N03AX09

ATC

lamotrigine; oral

2.2

22.2

236

1106

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

4.8

22.2

159

N06AB06

ATC

sertraline; oral

1.7

22.0

495

3045

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.8

22.0

409

2378

M25.5

ICD-10 Finland

Pain in joint

1.4

22.0

1237

9411

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

22.0

352

1945

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

21.9

486

2978

J01FA09

ATC

clarithromycin; systemic

1.4

21.8

1394

10848

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.1

21.8

270

1353

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

21.7

662

4420

G01AA10

ATC

clindamycin; vaginal

1.6

21.7

702

4757

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.4

21.6

105

311

SPAT1229

SPAT

Assessment of need for aid

1.9

21.5

337

1844

SPF10

NOMESCO Finland

Demanding repatation of teeth prosthesis

3.4

21.5

104

306

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

21.5

1221

9296

R06AX22

ATC

ebastine; oral

1.5

21.5

765

5296

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

21.4

892

6392

K08.2

ICD-10 Finland

Atrophy of edentulous alveolar ridge

4.4

21.4

179

B01AB05

ATC

enoxaparin; parenteral

1.4

21.4

1250

9570

N05AA02

ATC

levomepromazine; systemic

2.3

21.4

197

866

G01AF04

ATC

miconazole; vaginal

2.1

21.3

242

1170

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

21.3

675

4548

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

21.2

395

2296

K92.1

ICD-10 Finland

Melaena

2.2

21.0

216

1000

R03BB01

ATC

ipratropium bromide; inhalant

2.5

21.0

170

698

L03

ICPC

Low back symptom/complaint

1.4

20.9

1038

7700

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

2.6

20.9

153

594

SPAT1325

SPAT

Vaccination

1.4

20.8

1448

11415

A01

ICPC

Pain general/multiple sites

1.9

20.8

337

1871

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

4.2

20.8

194

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.6

20.7

151

584

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.4

20.7

178

755

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.7

20.7

509

3211

C01DA14

ATC

isosorbide mononitrate; oral

1.6

20.7

515

3260

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.8

20.6

372

2137

EBA00

NOMESCO Finland

Extraction of tooth

1.4

20.6

1372

10731

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

20.6

789

5546

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.4

20.6

177

750

SPAT1312

SPAT

General health counselling

1.4

20.6

1447

11427

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

20.6

310

1676

Z51.5

ICD-10 Finland

Palliative care

2.1

20.5

233

1127

TEA00

NOMESCO Finland

Biopsy of lip

4.5

20.5

160

A11CC03

ATC

alfacalcidol; systemic

3.0

20.4

121

413

NF1AA

NOMESCO Finland

Hip X-ray examination

1.8

20.4

350

1977

R05FB02

ATC

cough suppressants and expectorants

1.4

20.4

1585

12721

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.3

20.4

188

827

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

20.4

352

1996

G01AF05

ATC

econazole; vaginal

1.8

20.4

370

2133

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.9

20.4

331

1836

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.4

20.3

169

704

N05BA06

ATC

lorazepam; systemic, sublingual

2.1

20.3

228

1098

SPAT1310

SPAT

Counselling related to known health issue

1.4

20.3

1401

11022

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

20.2

2416

20703

A07AA09

ATC

vancomycin; oral

4.3

20.2

176

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.5

20.2

763

5348

R05

ICPC

Cough

1.4

20.2

961

7067

P01BA02

ATC

hydroxychloroquine; oral

1.8

20.1

373

2162

C10AC01

ATC

colestyramine; oral

2.8

20.1

133

487

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.2

20.0

198

900

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.2

20.0

200

912

C03.1

ICD-10 Finland

Malignant neoplasm: Lower gum

13.7

20.0

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

19.9

734

5111

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

19.8

323

1795

1120A

ICD-9 Finland

Candidiasis, Of mouth[CANDIDIASIS ORALIS]

+∞

19.8

K08.80

ICD-10 Finland

Toothache NOS

1.8

19.8

363

2099

T78.4

ICD-10 Finland

Allergy, unspecified

2.1

19.8

224

1083

N05BB01

ATC

hydroxyzine; systemic

1.9

19.8

290

1553

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

19.6

245

1232

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.0

19.6

247

1246

D01

ICPC

Abdominal pain/cramps general

1.6

19.6

484

3054

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.3

19.6

297

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.0

19.6

114

385

M48.0

ICD-10 Finland

Spinal stenosis

1.7

19.5

458

2849

R07.3

ICD-10 Finland

Other chest pain

1.7

19.5

388

2303

ZXA10

NOMESCO Finland

Bilateral

1.5

19.4

761

5368

Z94.0

ICD-10 Finland

Kidney transplant status

4.5

19.4

155

ZY010

NOMESCO Finland

Hospital outpatient

2.1

19.4

230

1131

R4190

NOMESCO Finland

Nutritional therapy

2.5

19.3

153

620

130

Kela drug reimbursment

Malignant tumour

1.9

19.3

315

1749

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

2.6

19.3

140

542

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

2.1

19.3

218

1052

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.1

19.3

234

1164

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

19.3

707

4920

L03AA02

ATC

filgrastim; parenteral

2.7

19.2

131

488

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.7

19.2

444

2751

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

19.2

1119

8531

SPAT1153

SPAT

Removal of sutures

1.4

19.2

1318

10340

N05BA12

ATC

alprazolam; oral

1.7

19.2

448

2782

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

19.2

1368

10800

M01AB05

ATC

diclofenac; systemic, rectal

1.3

19.2

2922

25844

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

19.2

686

4746

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

7.0

19.1

EJB10

NOMESCO Finland

Excision of lesion of apex or body of tongue

8.6

19.1

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

19.1

372

2190

J31.0

ICD-10 Finland

Chronic rhinitis

1.8

19.1

337

1925

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.9

19.1

116

403

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.1

19.0

212

1018

R52.9

ICD-10 Finland

Pain, unspecified

1.8

19.0

365

2140

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.2

19.0

204

965

R03DA04

ATC

theophylline; systemic, rectal

2.1

19.0

218

1061

L43.3

ICD-10 Finland

Subacute (active) lichen planus

11.4

18.9

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.4

18.9

279

D07XC01

ATC

betamethasone, combinations; topical

1.6

18.9

480

3056

SPAT1216

SPAT

Assessment of functional ability

1.5

18.8

601

4050

B00.2

ICD-10 Finland

Herpesviral gingivostomatitis and pharyngotonsillitis

9.1

18.8

F45.8

ICD-10 Finland

Other somatoform disorders

1.8

18.8

329

1873

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

18.8

228

1135

K59.1

ICD-10 Finland

Functional diarrhoea

2.1

18.7

223

1100

J01FA15

ATC

telithromycin; oral

1.7

18.7

436

2708

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

18.7

1046

7913

SPAT1260

SPAT

Consultation of another employee

1.5

18.7

770

5489

K03.66

ICD-10 Finland

Tooth plaque

1.9

18.7

275

1472

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

8.3

18.6

P76

ICPC

Depressive disorder

1.9

18.6

290

1586

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.5

18.6

143

573

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.5

18.6

246

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

18.6

413

2532

D07AB08

ATC

desonide; topical

1.6

18.6

453

2848

P01

ICPC

Feeling anxious/nervous/tense

1.6

18.5

467

2962

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.0

18.5

257

1348

R35

ICD-10 Finland

Polyuria

2.0

18.5

245

1264

D06BB04

ATC

podophyllotoxin; topical

1.9

18.4

261

1379

N30

ICD-10 Finland

Cystitis

1.8

18.4

347

2021

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

18.4

548

3626

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.8

18.4

315

1782

B35.3

ICD-10 Finland

Tinea pedis

2.5

18.3

147

602

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.6

18.3

133

515

XKD00

NOMESCO Finland

Uroflowmetry

1.6

18.3

520

3404

SPAT1234

SPAT

Support of social functional capacity

2.1

18.3

220

1091

A12AA04

ATC

calcium carbonate; oral

3.5

18.3

244

L01

ICPC

Neck symptom/complaint

1.5

18.2

583

3928

K92.0

ICD-10 Finland

Haematemesis

3.0

18.2

107

364

S29

ICPC

Skin symptom/complaint other

1.5

18.2

682

4760

M04AA01

ATC

allopurinol; systemic

1.7

18.2

435

2722

R52.2

ICD-10 Finland

Other chronic pain

2.4

18.2

158

674

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.2

18.2

185

851

E87.5

ICD-10 Finland

Hyperkalaemia

3.9

18.1

195

K13.28

ICD-10 Finland

Other leukoplakia or disorder of epithelium of the palate or tongue

8.9

18.1

D70.82

ICD-10 Finland

Drug-induced neutropenia

3.3

18.1

289

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.9

18.0

269

1449

SPD00

NOMESCO Finland

Fitting and preparation of total teeth prosthesis

4.3

18.0

154

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.7

17.9

121

450

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.2

17.9

182

839

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.4

17.9

1071

8191

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

17.9

1743

14405

C07AA05

ATC

propranolol; systemic

1.4

17.9

827

6031

R68.2

ICD-10 Finland

Dry mouth, unspecified

5.2

17.8

107

C03.0

ICD-10 Finland

Malignant neoplasm: Upper gum

26.8

17.8

K07.60

ICD-10 Finland

Snapping jaw

2.0

17.8

235

1210

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.4

17.7

902

6698

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.1

17.7

207

1015

C08CA01

ATC

amlodipine; oral

1.4

17.7

1294

10230

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.2

17.7

185

863

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

17.7

527

3489

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

17.7

299

1682

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.6

17.7

455

2902

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

17.7

1505

12188

ULA02

NOMESCO Finland

Kolposcopy

1.6

17.6

444

2815

EBA10

NOMESCO Finland

Surgical removal of tooth

1.6

17.6

517

3411

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

17.6

276

1515

N07BB01

ATC

disulfiram; oral

2.2

17.5

181

839

WX290

NOMESCO Finland

Other blockade of nerve

1.3

17.5

1907

16003

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

4.6

17.5

131

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

17.4

565

3815

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.9

17.4

183

Z71.8

ICD-10 Finland

Other specified counselling

1.4

17.4

1007

7656

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.7

17.4

208

H03AA01

ATC

levothyroxine sodium; systemic

1.4

17.3

1040

7952

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

17.3

1612

13219

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.6

17.3

541

3623

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

17.2

249

1326

WX882

NOMESCO Finland

High dependency care

2.5

17.2

131

524

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.9

17.1

263

1433

N05BE01

ATC

buspirone; oral

2.5

17.1

133

536

EBB10

NOMESCO Finland

Insertion of dental implant

3.4

17.1

247

B37

ICD-10 Finland

Candidiasis

9.3

17.1

H02AB02

ATC

dexamethasone; systemic

1.6

17.1

421

2656

U07

ICPC

Urine symptom/complaint other

1.9

17.1

246

1309

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

17.0

314

1819

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.8

17.0

288

1620

U02

ICPC

Urinary frequency/urgency

1.5

17.0

560

3797

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

3.3

17.0

254

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

17.0

1026

7854

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

16.9

891

6652

K14.61

ICD-10 Finland

Glossodynia

4.7

16.9

122

J47

ICD-10 Finland

Bronchiectasis

3.2

16.9

287

ZXE00

NOMESCO Finland

One hour or less

1.3

16.9

1704

14123

R03AK11

ATC

formoterol and fluticasone; inhalant

2.7

16.9

118

449

TQW80

NOMESCO Finland

Local dermatologic skincare

2.7

16.9

120

459

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

3.2

16.8

288

D01BA02

ATC

terbinafine; oral; topical

1.4

16.8

930

7006

L43.0

ICD-10 Finland

Hypertrophic lichen planus

6.3

16.8

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.0

16.8

333

R10.0

ICD-10 Finland

Acute abdomen

2.4

16.8

144

613

M54

ICD-10 Finland

Dorsalgia

1.6

16.8

473

3087

D07BC01

ATC

betamethasone and antiseptics; topical

1.6

16.7

477

3126

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

16.7

272

1513

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.6

16.7

121

471

B35.1

ICD-10 Finland

Tinea unguium

2.1

16.6

196

963

SBA10

NOMESCO Finland

Measurement of excretion of saliva

4.1

16.6

157

R01AD11

ATC

triamcinolone; nasal

1.7

16.6

392

2444

E86

ICD-10 Finland

Volume depletion

2.9

16.6

102

359

T90

ICPC

Diabetes non-insulin dependent

1.4

16.5

821

6058

B03XA02

ATC

darbepoetin alfa; parenteral

3.2

16.5

270

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

16.5

442

2848

A04AA02

ATC

granisetron; systemic, transdermal

1.9

16.5

254

1385

K20

ICD-10 Finland

Oesophagitis

3.2

16.5

265

N06AA12

ATC

doxepin; systemic

2.0

16.5

223

1158

ZXA05

NOMESCO Finland

Left side

1.4

16.5

993

7591

K13.22

ICD-10 Finland

Erythroplakia of oral epithelium, including tongue

10.7

16.4

ZZA00

NOMESCO Finland

Split skin graft

2.6

16.4

122

481

R01AD01

ATC

beclometasone; nasal

1.5

16.4

632

4436

V03AE01

ATC

polystyrene sulfonate; oral

4.1

16.4

159

R06AX27

ATC

desloratadine; oral

1.4

16.4

1174

9236

WW200

NOMESCO Finland

Immunization

2.5

16.3

131

537

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.8

16.3

114

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.3

16.2

151

669

A07EC02

ATC

mesalazine; oral, rectal

1.9

16.2

241

1298

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

6.8

16.2

F32

ICD-10 Finland

Depressive episode

1.9

16.1

237

1271

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.6

16.1

206

SPAT1240

SPAT

Therapeutic discussion

1.6

16.1

487

3232

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

16.1

469

3084

K29.7

ICD-10 Finland

Gastritis, unspecified

2.2

16.1

158

716

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.8

16.1

105

384

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.5

16.1

212

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

7.0

16.1

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.3

16.0

244

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

16.0

198

993

64091

ICD-8 Finland

Medical termination of pregnancy, Weakness (medical-social reason)

2.0

16.0

194

967

D11

ICPC

Diarrhoea

1.6

16.0

477

3158

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

15.9

223

1174

N18.8

ICD-10 Finland

Other chronic renal failure

2.7

15.8

108

406

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

15.8

345

2100

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.2

15.8

252

H25.8

ICD-10 Finland

Other senile cataract

1.7

15.7

364

2252

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.5

15.7

518

3509

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.9

15.7

249

1372

UJC12

NOMESCO Finland

Flexible oesophagoscopy

5.1

15.7

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.3

15.7

248

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.1

15.7

281

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

15.7

1294

10394

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

3.7

15.6

181

1120B

ICD-9 Finland

Candidiasis, Of mouth[CANDIDIASIS REGIONIS GASTROINTESTITIALIS]

+∞

15.6

A02BA03

ATC

famotidine; systemic

2.2

15.6

165

775

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

15.6

528

3596

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

15.6

259

1450

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

15.6

188

935

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.6

15.5

114

447

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

15.5

758

5570

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

15.5

980

7538

R07.0

ICD-10 Finland

Pain in throat

1.8

15.5

275

1571

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

15.5

305

1799

M05BA04

ATC

alendronic acid; oral

1.7

15.5

317

1893

M05BX04

ATC

denosumab; parenteral

2.0

15.5

197

1002

L02

ICPC

Back symptom/complaint

1.6

15.4

382

2408

D06BB03

ATC

aciclovir; topical

1.9

15.4

213

1116

EJ2S1

NOMESCO Finland

Photography of oral mucosa

10.8

15.4

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

15.4

217

1147

S02

ICPC

Pruritus

2.2

15.4

159

741

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

5.3

15.4

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

15.3

1340

10846

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.1

15.3

180

886

D01AC03

ATC

econazole; topical

1.9

15.3

238

1303

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

15.3

226

1214

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.3

15.3

1183

9403

B01AC04

ATC

clopidogrel; oral

1.5

15.3

520

3550

W19

ICD-10 Finland

Unspecified fall

1.7

15.3

361

2250

A10BH01

ATC

sitagliptin; oral

1.7

15.2

338

2070

J45.8

ICD-10 Finland

Mixed asthma

2.3

15.2

136

590

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

4.8

15.2

105

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

15.2

2486

21871

SPA47

NOMESCO Finland

Precision impression for denture

3.3

15.2

238

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.8

15.1

356

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.9

15.1

327

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

15.0

338

2078

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

15.0

251

1409

N06AA10

ATC

nortriptyline; systemic

2.7

15.0

105

400

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

14.9

411

2665

R04.2

ICD-10 Finland

Haemoptysis

2.4

14.9

131

563

G04CA02

ATC

tamsulosin; oral

1.5

14.9

646

4636

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

5.5

14.9

R63.4

ICD-10 Finland

Abnormal weight loss

2.3

14.9

142

636

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

3.9

14.9

154

RD210

NOMESCO Finland

2.9

14.8

319

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

14.8

334

2051

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.7

14.8

287

1689

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.3

14.8

221

E87.6

ICD-10 Finland

Hypokalaemia

2.3

14.8

133

578

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

14.8

265

1521

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.6

14.8

414

2699

N76.3

ICD-10 Finland

Subacute and chronic vulvitis

4.2

14.8

136

D06

ICPC

Abdominal pain localized other

1.6

14.7

353

2209

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.5

14.7

111

442

E66.8

ICD-10 Finland

Other obesity

1.9

14.7

223

1211

C03DA01

ATC

spironolactone; oral

1.6

14.7

388

2489

L30.4

ICD-10 Finland

Erythema intertrigo

3.4

14.7

207

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

2.7

14.6

369

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.9

14.6

226

1234

E000003

ATC

2.0

14.6

190

975

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

5.4

14.6

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

5.4

14.6

N02AC04

ATC

dextropropoxyphene; oral

2.2

14.6

145

662

SPAT1104

SPAT

Monitoring of emergency patient

1.8

14.6

270

1564

R01AD12

ATC

fluticasone furoate; nasal

1.3

14.6

1269

10252

JAH01

NOMESCO Finland

Laparoscopy

2.0

14.6

198

1033

J01AA07

ATC

tetracycline; systemic

1.4

14.5

641

4619

H62.2*B37.2

ICD-10 Finland

Otitis externa in candidiasis

150.4

14.5

U05

ICPC

Urination problems other

2.1

14.5

173

857

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.2

14.4

144

658

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.4

14.4

120

504

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.1

14.4

139

D09

ICPC

Nausea

2.0

14.4

182

923

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.5

14.4

545

3803

K13.00

ICD-10 Finland

Cheilitis NOS

6.2

14.3

N05AX08

ATC

risperidone; systemic

1.7

14.3

294

1757

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.3

14.3

211

C01CA24

ATC

epinephrine; parenteral

1.8

14.3

270

1577

A07EC01

ATC

sulfasalazine; oral, rectal

1.7

14.3

329

2035

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

14.3

649

4699

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.6

14.3

102

394

R03DC01

ATC

zafirlukast; oral

3.0

14.3

282

EB1WA

NOMESCO Finland

4.9

14.3

X57

ICD-10 Finland

Unspecified privation

2.6

14.3

101

388

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

14.3

251

1431

K22.2

ICD-10 Finland

Oesophageal obstruction

4.1

14.2

136

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.0

14.2

283

F34.1

ICD-10 Finland

Dysthymia

2.1

14.2

163

796

R30.0

ICD-10 Finland

Dysuria

2.1

14.2

157

752

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

14.2

2164

18810

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

14.2

535

3732

ZX121

NOMESCO Finland

Central venous catheter

7.4

14.2

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

5.9

14.2

SCA03

NOMESCO Finland

Preventive oral health care, extensive

1.9

14.1

203

1082

TAB00

NOMESCO Finland

Lumbar puncture

2.0

14.1

186

958

A09AA02

ATC

multienzymes (lipase, protease etc.)

2.9

14.1

291

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.5

14.1

112

460

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.1

14.1

166

818

L29.9

ICD-10 Finland

Pruritus, unspecified

2.5

14.1

111

454

C07AB02

ATC

metoprolol; systemic

1.4

14.1

762

5700

S76

ICPC

Skin infection other

1.9

14.1

196

1033

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.0

14.0

183

938

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.3

14.0

132

590

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.6

14.0

178

A07EA06

ATC

budesonide; oral, local oral

2.1

14.0

152

725

A01AC01

ATC

triamcinolone; local oral

2.8

14.0

322

N06AB05

ATC

paroxetine; oral

1.8

13.9

257

1493

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

13.8

373

2406

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.1

13.8

162

798

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.3

13.8

124

542

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.9

13.7

279

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

13.7

189

990

JAH00

NOMESCO Finland

Laparotomy

2.4

13.7

112

467

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

13.7

215

1183

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.9

13.7

280

EDB00

NOMESCO Finland

Partial excision of mandible

9.7

13.7

M02AA10

ATC

ketoprofen; topical

1.4

13.7

627

4547

K11.2

ICD-10 Finland

Sialoadenitis

2.2

13.6

136

624

WX725

NOMESCO Finland

Noninvasive ventilation

1.9

13.6

184

961

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

3.4

13.5

194

SPA02

NOMESCO Finland

Preparation for dental prosthetics

2.6

13.5

359

P29

ICPC

Psychological sympt/compl other

1.8

13.5

239

1368

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

13.5

298

1825

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.9

13.5

197

1055

K02.0

ICD-10 Finland

Caries limited to enamel

1.5

13.5

573

4096

K14.60

ICD-10 Finland

Glossopyrosis

5.2

13.4

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.1

13.4

159

787

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.9

13.4

183

958

B81

ICPC

Anaemia vit B12/folate deficiency

2.1

13.4

144

683

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.9

13.3

196

1053

I50.0

ICD-10 Finland

Congestive heart failure

1.8

13.3

217

1206

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.8

13.3

145

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.9

13.3

280

N06AX12

ATC

bupropion; oral

1.7

13.3

264

1567

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

13.3

151

735

X15

ICPC

Vaginal symptom/complaint other

2.0

13.3

164

824

A03

ICPC

Fever

1.4

13.3

652

4790

K12.12

ICD-10 Finland

Stomatitis ulcerative

5.4

13.2

RS221

NOMESCO Finland

3.1

13.2

241

NHQ40

NOMESCO Finland

Amputation of toe

3.1

13.2

241

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

13.2

1610

13574

N05AF03

ATC

chlorprothixene; systemic

2.3

13.2

117

507

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.5

13.2

105

431

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.2

13.2

134

622

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

13.2

1531

12827

G04BD12

ATC

mirabegron; oral

1.6

13.2

363

2356

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

13.1

387

2551

A02BX02

ATC

sucralfate; oral

2.0

13.1

159

794

R4180

NOMESCO Finland

Podiatric therapy

3.8

13.1

142

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.8

13.1

142

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

6.1

13.1

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.0

13.1

178

928

H04AA01

ATC

glucagon; nasal, parenteral

2.4

13.1

107

446

M54.2

ICD-10 Finland

Cervicalgia

1.7

13.0

290

1776

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.0

13.0

156

777

E000002

ATC

1.5

13.0

474

3282

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.1

13.0

149

729

B01AA03

ATC

warfarin; systemic

1.4

12.9

668

4953

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

12.9

1781

15236

RS220

NOMESCO Finland

3.1

12.9

229

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.9

12.9

202

1112

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

12.8

163

828

M81.4

ICD-10 Finland

Drug-induced osteoporosis

7.7

12.8

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.3

12.8

120

535

A10BA02

ATC

metformin; oral

1.3

12.8

980

7743

N06AX03

ATC

mianserin; oral

1.9

12.8

197

1076

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.6

12.7

366

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.3

12.7

120

538

D01AE15

ATC

terbinafine; topical

1.7

12.7

255

1516

E83.50

ICD-10 Finland

Hypercalcemia

3.4

12.7

177

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.5

12.7

377

X14

ICPC

Vaginal discharge

2.4

12.7

106

448

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

3.0

12.7

247

U01

ICPC

Dysuria/painful urination

1.6

12.7

317

2005

H65.2

ICD-10 Finland

Chronic serous otitis media

3.5

12.7

162

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

2.2

12.7

127

585

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.1

12.7

137

653

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

4.5

12.7

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

12.6

151

752

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.7

12.6

330

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

7.8

12.6

D02AE01

ATC

carbamide; topical

1.7

12.6

282

1732

H26.3

ICD-10 Finland

Drug-induced cataract

4.6

12.5

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

3.0

12.5

234

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

8.2

12.5

N06AX05

ATC

trazodone; oral

2.3

12.5

118

529

N07BA03

ATC

varenicline; oral

1.8

12.5

197

1086

R63.8

ICD-10 Finland

Other symptoms and signs concerning food and fluid intake

8.7

12.5

ZXA00

NOMESCO Finland

Right side

1.3

12.5

1046

8378

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.2

12.4

125

575

J01AA04

ATC

lymecycline; systemic

1.4

12.4

542

3893

137

Kela drug reimbursment

Uraemia requiring dialysis

4.0

12.4

120

L14

ICPC

Leg/thigh symptom/complaint

1.7

12.4

277

1699

D01AE16

ATC

amorolfine; topical

1.5

12.4

434

2976

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

12.3

550

3963

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

12.3

469

3277

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.4

12.3

106

455

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.0

12.3

153

774

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.7

12.3

323

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

3.5

12.3

161

B35.4

ICD-10 Finland

Tinea corporis

3.9

12.3

126

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.8

12.3

214

1221

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.8

12.2

202

1129

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.8

12.2

226

1314

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

2.6

12.2

350

Z00.0

ICD-10 Finland

General medical examination

1.4

12.2

731

5555

N03AX11

ATC

topiramate; oral

2.3

12.2

116

522

SPA50

NOMESCO Finland

Determination of bite and dental arch location

4.0

12.2

122

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.0

12.2

147

733

N04BC05

ATC

pramipexole; oral

1.7

12.2

273

1676

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.1

12.2

138

672

C06.0

ICD-10 Finland

Malignant neoplasm: Cheek mucosa

15.9

12.1

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

12.1

578

4221

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.3

12.1

1047

8414

SFA00

NOMESCO Finland

Small filling

1.5

12.1

505

3594

WX199

NOMESCO Finland

Other local analgesia

2.4

12.1

102

434

SPAT1167

SPAT

Insertion of urinary catheter

2.2

12.1

120

551

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.9

12.0

180

976

J01DC02

ATC

cefuroxime; systemic

1.7

12.0

236

1395

L60.0

ICD-10 Finland

Ingrowing nail

1.9

12.0

165

866

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

4.0

12.0

119

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.7

12.0

258

1568

A06AC51

ATC

ispaghula, combinations; systemic

1.8

12.0

196

1093

B00.11

ICD-10 Finland

Herpes simplex labialis

2.9

12.0

241

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.6

11.9

342

N77.1*A60.0

ICD-10 Finland

Vaginitis, vulvitis and vulvovaginitis in herpesviral [herpes simplex] infection

5.2

11.9

L84

ICD-10 Finland

Corns and callosities

2.2

11.9

124

582

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

3.6

11.9

145

EBB15

NOMESCO Finland

Insertion of dental implant abutment

3.7

11.9

135

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

3.9

11.8

121

TQW99

NOMESCO Finland

Other minor procedure on skin

1.9

11.8

181

989

F05.9

ICD-10 Finland

Delirium, unspecified

2.8

11.8

267

UJH02

NOMESCO Finland

Anoscopy

1.9

11.7

165

874

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

2.3

11.7

110

492

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.4

11.7

511

3668

N06AG02

ATC

moclobemide; oral

1.9

11.7

181

993

L40.8

ICD-10 Finland

Other psoriasis

4.0

11.7

117

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.2

11.7

195

S06.0

ICD-10 Finland

Concussion

1.5

11.7

394

2682

N05AX12

ATC

aripiprazole; systemic

1.9

11.6

158

825

N06AX26

ATC

vortioxetine; oral

1.7

11.6

226

1333

SBB20

NOMESCO Finland

Tooth X-ray examination in conjunction with visit to dentist

3.4

11.6

158

B37.05

ICD-10 Finland

Candidal granuloma of mouth

30.1

11.6

R2110

NOMESCO Finland

Giving the first information

1.6

11.6

290

1837

UDM02

NOMESCO Finland

Sinoscopy

2.4

11.6

390

KCV04

NOMESCO Finland

Distension of bladder with fluid

3.3

11.5

175

R15

ICD-10 Finland

Faecal incontinence

2.3

11.5

109

490

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

11.5

401

2747

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.6

11.5

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.1

11.5

192

R06.5

ICD-10 Finland

Mouth breathing

1.6

11.5

308

1987

N05AN01

ATC

lithium; oral

2.3

11.5

108

483

EMAK

NOMESCO Finland

1.9

11.5

159

839

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

11.5

420

2908

K13.21

ICD-10 Finland

Leukoplakia caused by tobacco

9.2

11.5

E31.00

ICD-10 Finland

APECED syndrome

+∞

11.5

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

5.3

11.5

A10AA02

ATC

2.1

11.5

133

655

SPD05

NOMESCO Finland

Demanding fitting of total teeth prosthesis

5.9

11.4

J01CF05

ATC

flucloxacillin; systemic

2.0

11.4

148

759

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

13.6

11.4

R81

ICPC

Pneumonia

2.1

11.4

126

608

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.3

11.4

166

F32.1

ICD-10 Finland

Moderate depressive episode

1.7

11.4

222

1311

X72

ICPC

Genital candidiasis female

3.0

11.4

210

A10AA01

ATC

2.2

11.4

111

508

P03

ICPC

Feeling depressed

1.5

11.4

370

2500

SPAT1125

SPAT

Stoma care and guidance

3.0

11.4

219

R31

ICD-10 Finland

Unspecified haematuria

1.6

11.3

317

2064

M01AX17

ATC

nimesulide; oral

1.3

11.3

930

7412

SPAT1324

SPAT

Screening procedure

0.7

11.3

416

5721

TJD20

NOMESCO Finland

Change of gastrostomy tube

6.0

11.3

A05AA02

ATC

ursodeoxycholic acid; oral

2.6

11.3

328

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.1

11.3

122

581

J43.9

ICD-10 Finland

Emphysema, unspecified

3.1

11.3

189

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

5.3

11.3

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

4.1

11.3

102

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.1

11.3

102

UJF92

NOMESCO Finland

Capsular endoscopy

2.4

11.3

411

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.4

11.3

373

D05BB02

ATC

acitretin; oral

2.4

11.3

373

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

3.3

11.2

168

H02BX01

ATC

methylprednisolone, combinations; systemic

1.8

11.2

192

1091

EEB00

NOMESCO Finland

Partial excision of maxilla

17.0

11.2

L12

ICPC

Hand/finger symptom/complaint

1.4

11.2

541

3956

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.8

11.2

252

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.5

11.1

396

2723

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.1

11.1

124

602

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.7

11.1

266

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.5

11.0

369

2505

SPAT1172

SPAT

Guidance concerning hydration

2.4

11.0

382

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.0

11.0

147

763

B07.9

ICD-10 Finland

Verruca simplex

2.0

11.0

136

684

S06

ICPC

Rash localized

1.7

11.0

215

1271

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.7

11.0

239

1458

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.9

11.0

155

821

Z72.0

ICD-10 Finland

Tobacco use

2.3

11.0

422

EHB00

NOMESCO Finland

Excision of lesion of palate

8.6

11.0

L29.2

ICD-10 Finland

Pruritus vulvae

2.8

11.0

256

K60.1

ICD-10 Finland

Chronic anal fissure

2.3

10.9

415

A02BA04

ATC

nizatidine; systemic

1.6

10.9

294

1896

J96.0

ICD-10 Finland

Acute respiratory failure

3.6

10.9

130

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

10.9

226

1360

SPE00

NOMESCO Finland

Fitting and preparation of metal structure partial teeth prosthesis

2.7

10.9

281

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.3

10.9

768

5982

SDA02

NOMESCO Finland

Parodonthologic therapy

1.3

10.9

1332

11180

R20.2

ICD-10 Finland

Paraesthesia of skin

1.6

10.9

259

1621

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.3

10.9

426

C08CA05

ATC

nifedipine; systemic

1.7

10.9

234

1423

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.1

10.9

189

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

10.9

260

1626

UDC00

NOMESCO Finland

Ear microscopy

1.6

10.9

265

1668

SPA10

NOMESCO Finland

Setting attachments on tooth or implanted bracket or imblant based structures

7.8

10.8

H57.1

ICD-10 Finland

Ocular pain

2.0

10.8

128

634

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

5.7

10.8

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.9

10.8

229

SPE90

NOMESCO Finland

Other fitting and preparation of partial tooth prosthesis

2.4

10.8

369

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.4

10.8

369

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

10.8

564

4181

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

2.8

10.8

235

ZX108

NOMESCO Finland

Inhalation

3.9

10.8

111

JN4CD

NOMESCO Finland

Very extensive body CT

2.0

10.8

137

699

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.3

10.8

431

R04.0

ICD-10 Finland

Epistaxis

1.6

10.8

248

1537

L15

ICPC

Knee symptom/complaint

1.3

10.8

793

6217

R51.81

ICD-10 Finland

Facial pain NOS

2.3

10.8

402

H02AA02

ATC

fludrocortisone; oral

4.0

10.8

102

WX720

NOMESCO Finland

Own respiration

2.0

10.8

139

716

8070/3-C02.1

ICD-O-3

Squamous cell carcinoma, NOS, of border of tongue

10.6

10.7

S04

ICPC

Lump/swelling localized

1.5

10.7

362

2464

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.9

10.7

159

862

J01XC01

ATC

fusidic acid; systemic

3.0

10.7

197

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

4.1

10.7

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.3

10.7

100

448

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

2.9

10.6

220

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

6.7

10.6

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.0

10.6

127

634

B02AA02

ATC

tranexamic acid; systemic

1.4

10.6

600

4510

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

3.8

10.6

113

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

10.6

150

798

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.5

10.6

316

D06BB10

ATC

imiquimod; topical

1.8

10.6

186

1064

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.7

10.6

250

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.1

10.6

112

529

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.8

10.6

236

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.7

10.6

274

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.0

10.6

137

705

R12

ICD-10 Finland

Heartburn

1.6

10.6

276

1766

H01

ICPC

Ear pain/earache

1.5

10.6

427

3018

SPA20

NOMESCO Finland

Selection and insertion of implantdistans

5.5

10.5

T74.1

ICD-10 Finland

Physical abuse

2.5

10.5

318

K05.31

ICD-10 Finland

Periodontitis pronounced

1.5

10.5

326

2180

U71

ICPC

Cystitis/urinary infection other

1.6

10.5

242

1502

L04AA13

ATC

leflunomide; oral

2.1

10.5

110

521

A07AA11

ATC

rifaximin; oral

10.0

10.5

Z94.2

ICD-10 Finland

Lung transplant status

9.2

10.5

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

1.5

10.5

327

2186

H01.0

ICD-10 Finland

Blepharitis

1.7

10.5

208

1236

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.3

10.5

934

7523

S21

ICPC

Skin texture symptom/complaint

1.4

10.5

467

3367

D02

ICPC

Abdominal pain epigastric

1.7

10.5

225

1369

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.1

10.5

121

596

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.7

10.4

230

1409

A10BB12

ATC

glimepiride; oral

1.7

10.4

235

1449

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.1

10.4

111

526

R52.0

ICD-10 Finland

Acute pain

2.0

10.4

128

647

WX402

NOMESCO Finland

General anaesthesia

1.4

10.4

635

4832

K12.00

ICD-10 Finland

Recurrent oral aphthae

2.8

10.4

224

M01AC06

ATC

meloxicam; systemic, rectal

1.2

10.4

1460

12441

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.6

10.4

289

M01AH02

ATC

rofecoxib; oral

1.4

10.4

491

3578

B01AB04

ATC

dalteparin; parenteral

1.8

10.3

184

1058

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.0

10.3

131

668

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.9

10.3

150

806

M79.7

ICD-10 Finland

Fibromyalgia

1.9

10.3

144

763

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

12.0

10.3

R41.0

ICD-10 Finland

Disorientation, unspecified

2.2

10.3

443

L08

ICPC

Shoulder symptom/complaint

1.3

10.3

689

5318

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

2.7

10.3

259

LCH11

NOMESCO Finland

Pharmacologic abortion

1.8

10.3

163

902

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

8.2

10.3

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.7

10.3

201

1188

SPA60

NOMESCO Finland

Fitting of intermediary dental prosthesis structures, 1 to 3 units

3.2

10.3

169

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.1

10.3

115

559

EKB00

NOMESCO Finland

Excision of lesion of cheek

5.1

10.3

R95

ICPC

Chron obstructive pulmonary disease

2.3

10.3

393

A03CA02

ATC

clidinium and psycholeptics; oral

1.7

10.2

218

1324

UJC02

NOMESCO Finland

Rigid oesophagoscopy

3.6

10.2

122

S10

ICPC

Boil/carbuncle

1.7

10.2

204

1216

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

4.7

10.2

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

3.4

10.2

138

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.4

10.2

340

D82

ICPC

Teeth/gum disease

1.2

10.2

1418

12065

SPAT1058

SPAT

PEF monitoring instruction

1.5

10.2

319

2136

H65.3

ICD-10 Finland

Chronic mucoid otitis media

2.4

10.1

342

ZX112

NOMESCO Finland

Subcutaneous

2.4

10.1

361

NGQ20

NOMESCO Finland

Amputation of lower leg

5.4

10.1

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

10.1

288

1887

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

10.1

4156

39663

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

10.0

622

4745

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

2.8

10.0

227

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.6

10.0

274

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.7

10.0

185

1077

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.7

10.0

258

EJB40

NOMESCO Finland

Hemiglossectomy

11.3

10.0

N06AA04

ATC

clomipramine; systemic

2.5

10.0

308

K08.3

ICD-10 Finland

Retained dental root

1.6

10.0

234

1458

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

3.1

10.0

167

SPF03

NOMESCO Finland

Impression for dental prosthesis repair, demanding

4.1

10.0

318

Kela drug reimbursment

Teriparatide

4.9

10.0

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.8

10.0

175

1000

I95.1

ICD-10 Finland

Orthostatic hypotension

2.1

10.0

110

530

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

4.3

10.0

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.0

10.0

117

580

R06.4

ICD-10 Finland

Hyperventilation

2.5

9.9

321

Z01.9

ICD-10 Finland

Special examination, unspecified

1.7

9.9

208

1256

F10.24

ICD-10 Finland

Alcohol depence active use

2.9

9.9

201

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

9.9

1698

14767

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.0

9.9

119

595

A97

ICPC

No disease

1.4

9.9

566

4259

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.8

9.9

171

975

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.5

9.9

296

N05AB03

ATC

perphenazine; systemic, rectal

1.9

9.9

142

760

R29

ICPC

Respiratory symptom/complaint other

1.6

9.9

242

1524

R00.2

ICD-10 Finland

Palpitations

1.6

9.9

278

1813

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

2.1

9.9

107

512

N05BA02

ATC

chlordiazepoxide; systemic

2.3

9.8

393

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.7

9.8

205

1236

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.7

9.8

193

1145

N94.1

ICD-10 Finland

Dyspareunia

2.7

9.8

249

C04.0

ICD-10 Finland

Malignant neoplasm: Anterior floor of mouth

20.0

9.8

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.2

9.8

159

WX610

NOMESCO Finland

Patient controlled analgesia

3.8

9.7

107

M05BA07

ATC

risedronic acid; oral

2.0

9.7

120

607

V03AA01

ATC

2.8

9.7

227

M75

ICD-10 Finland

Shoulder lesions

1.8

9.7

156

866

M10.9

ICD-10 Finland

Gout, unspecified

1.7

9.7

184

1081

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

9.7

308

2068

E83.51

ICD-10 Finland

Hypocalcemia

4.5

9.7

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.2

9.7

451

G04BD08

ATC

solifenacin; oral

1.6

9.7

229

1431

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.5

9.7

309

2080

AN1

Coronary angiography

1.5

9.7

358

2485

K65.0

ICD-10 Finland

Acute peritonitis

3.1

9.7

166

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

5.1

9.7

K50.8

ICD-10 Finland

Other Crohn disease

2.5

9.7

277

EBB11

NOMESCO Finland

Insertion of additional dental implant in one session

3.8

9.7

103

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

6.1

9.7

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.6

9.6

253

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

9.6

1139

9494

J01

ICD-10 Finland

Acute sinusitis

1.7

9.6

193

1155

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.4

9.6

316

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

9.6

1651

14357

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.6

9.5

255

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.7

9.5

187

1109

S00.0

ICD-10 Finland

Superficial injury of scalp

2.4

9.5

336

V03AE02

ATC

sevelamer; oral

5.0

9.5

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

3.2

9.5

146

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.5

9.5

280

L03AA13

ATC

pegfilgrastim; parenteral

1.9

9.5

145

794

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.2

9.5

429

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

3.6

9.5

115

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

9.5

689

5388

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

2.9

9.4

197

R06AE09

ATC

levocetirizine; oral

1.4

9.4

592

4522

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.2

9.4

434

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.0

9.4

120

616

N17.8

ICD-10 Finland

Other acute renal failure

3.4

9.4

126

XX9XE

NOMESCO Finland

Other ultrasound examination

3.1

9.4

164

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.5

9.4

276

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.8

9.4

159

902

1122A

ICD-9 Finland

Candidiasis, Of other urogenital sites[CANDIDIASIS BALANITIS]

+∞

9.4

J17.2*B37.1

ICD-10 Finland

Pneumonia in candidiasis

+∞

9.4

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.2

9.4

449

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.8

9.3

164

940

2AX04

NOMESCO Finland

21.7

9.3

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

5.6

9.3

EAA10

NOMESCO Finland

Excision of lesion of lip

2.9

9.3

193

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.6

9.3

217

1354

B01AB10

ATC

tinzaparin; parenteral

1.6

9.3

253

1638

ZXC10

NOMESCO Finland

Use of laser

2.2

9.3

419

R06AX13

ATC

loratadine; oral

1.3

9.3

611

4705

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.3

9.3

133

R49.08

ICD-10 Finland

Other specified dysphonia

2.3

9.2

379

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

3.1

9.2

155

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.7

9.2

170

988

M01AX01

ATC

nabumetone; oral

1.7

9.2

167

969

K05.30

ICD-10 Finland

Periodontitis complex

1.4

9.2

436

3177

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

5.4

9.2

S80.0

ICD-10 Finland

Contusion of knee

1.6

9.2

244

1572

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.7

9.2

235

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.5

9.1

277

J01DA06

ATC

[U] cefuroxime; systemic

1.4

9.1

567

4324

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

4.8

9.1

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

9.1

234

1494

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.1

9.1

475

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

3.0

9.1

168

R4130

NOMESCO Finland

Speech therapy

2.3

9.1

355

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.2

9.1

397

SPC10

NOMESCO Finland

Attachment of standard crone of tooth

2.3

9.1

336

I95.9

ICD-10 Finland

Hypotension, unspecified

2.8

9.1

191

F45.0

ICD-10 Finland

Somatization disorder

4.6

9.1

G50.1

ICD-10 Finland

Atypical facial pain

2.4

9.0

318

EB1AD

NOMESCO Finland

Cone beam CT of teeth and jaws (one quarter)

4.1

9.0

H3601, E103

ICD-10 Finland

3.3

9.0

136

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

3.5

9.0

115

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

3.6

9.0

110

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.1

9.0

101

494

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.7

9.0

194

1186

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

3.1

9.0

153

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

3.2

9.0

142

K50.1

ICD-10 Finland

Crohn disease of large intestine

2.7

9.0

216

H05AA02

ATC

teriparatide; parenteral

4.8

9.0

M01CB01

ATC

sodium aurothiomalate; parenteral

2.5

8.9

265

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.5

8.9

258

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

8.9

183

1099

N17

ICPC

Vertigo/dizziness

1.4

8.9

400

2887

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

8.9

114

588

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

2.2

8.9

407

R01AD05

ATC

budesonide; nasal

1.5

8.9

298

2025

ICD-10 Finland

2.1

8.9

453

N19

ICD-10 Finland

Unspecified kidney failure

2.1

8.9

476

M01AH01

ATC

celecoxib; oral (coxibs)

1.3

8.9

675

5311

T82

ICPC

Obesity

1.8

8.8

147

830

L50.8

ICD-10 Finland

Other urticaria

2.4

8.8

316

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.1

8.8

100

491

Y84.9

ICD-10 Finland

Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.0

8.8

J32.4

ICD-10 Finland

Chronic pansinusitis

2.5

8.8

261

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.0

8.8

161

LCH13

NOMESCO Finland

Vacuum aspiration from uterus after medically induced abortion

2.4

8.8

290

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

4.9

8.8

XF640

NOMESCO Finland

2.0

8.8

104

520

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

3.2

8.8

139

A04AD12

ATC

aprepitant; systemic

2.3

8.8

358

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

8.8

285

1928

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

4.6

8.8

R55

ICD-10 Finland

Syncope and collapse

1.4

8.7

366

2607

U13

ICPC

Bladder symptom/complaint other

1.9

8.7

121

643

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.8

8.7

140

780

R25.2

ICD-10 Finland

Cramp and spasm

2.2

8.7

392

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

2.6

8.7

231

SPAT1210

SPAT

Application of cast or individual aid

1.7

8.7

167

983

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.0

8.7

101

500

DFF00

NOMESCO Finland

Pure tone audiometry

1.5

8.7

303

2076

SPD01

NOMESCO Finland

Mucosa-supported complete denture

3.5

8.7

108

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3026389) Candida sp identified in Specimen by Organism specific culture

588

654

9.93

307.65

2.1

1.2

—

(3000494) Fungus identified in Specimen by Culture

1380

5130

3.25

281.76

2.2

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

1203

5236

2.65

175.16

2.5

1.7

—

(3023368) Bacteria identified in Blood by Culture

2044

11331

2.27

173.59

8.2

4.1

—

(3013115) Eosinophils [#/volume] in Blood

3417

23778

2.13

156.26

10.2

5.9

e9/l

0.2

0.05

3064

20928

(42870588) Differential panel, method unspecified - Blood

2487

15430

2.10

153.88

9.7

5.8

—

(3042936) Bacteria identified in Isolate by Culture

1283

6097

2.43

152.88

2.9

1.9

—

(3006315) Basophils [#/volume] in Blood

3316

22996

2.09

150.64

9.6

5.7

e9/l

0.0

0.83

2969

19860

(3001604) Monocytes [#/volume] in Blood

3301

22901

2.08

149.18

9.6

5.7

e9/l

0.6

3.50

2963

19790

(3019198) Lymphocytes [#/volume] in Blood

3366

23609

2.07

146.49

9.7

5.7

e9/l

1.9

0.95

3040

20834

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

806

3153

2.82

142.35

2.4

1.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1363

6885

2.30

139.63

2.6

1.8

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2957

20016

2.02

139.26

11.5

5.6

mmol/l

1.2

6.38

2665

18087

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3295

23245

2.02

137.16

10.1

5.9

umol/l

10.6

11.1

1.21

3107

21968

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1355

6945

2.26

133.24

6.9

3.2

mmol/l

0.8

2.71

1270

6454

(3019069) Monocytes/100 leukocytes in Blood

3102

21635

1.98

130.88

10.6

6.2

8.4

8.5

0.39

2916

20263

(3013650) Neutrophils [#/volume] in Blood by Automated count

3616

26598

2.02

130.82

14.8

8.8

e9/l

4.3

4.1

9.55

3259

23209

(3022096) Basophils/100 leukocytes in Blood

3017

20873

1.97

129.99

10.0

6.0

0.6

0.7

2.23

2814

19464

(3006504) Eosinophils/100 leukocytes in Blood

3084

21526

1.97

129.14

10.0

5.9

2.7

2.8

2.92

2888

20041

(3002030) Lymphocytes/100 leukocytes in Blood

3159

22274

1.97

127.90

10.3

6.0

26.8

28.4

13.27

2948

20752

(3018010) Neutrophils/100 leukocytes in Blood

3116

21969

1.95

125.03

9.8

5.8

58.6

57.0

10.08

2917

20539

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2222

14103

1.96

120.70

3.8

2.5

u/l

54.5

57.7

2.70

2046

12997

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3110

22132

1.92

118.87

12.6

6.3

mmol/l

1.2

4.71

2623

18631

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1108

5510

2.26

115.32

10.2

5.6

mmol/l

1.1

1.0

0.44

1035

5122

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

355

967

3.85

112.97

2.3

1.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2761

19104

1.88

112.94

8.3

4.6

g/l

34.4

35.7

24.96

2569

17723

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

459

1538

3.16

105.74

2.8

1.9

ug/l

1.6

2.1

0.52

408

1363

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

341

948

3.77

105.26

2.4

1.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1422

8047

2.03

104.57

1.9

1.7

nmol/l

1215.0

1158.4

1.42

1068

6097

(3031040) Bacteria [#/volume] in Urine by Automated count

3946

31008

1.93

104.46

7.3

4.4

e6/l

56.8

1501.9

4.80

390

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1855

11528

1.91

103.58

3.0

2.2

mg/l

3.2

2.9

5.39

1594

9873

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

312

827

3.94

103.07

12.1

5.0

iu/ml

943.7

652.4

0.22

111

(3020779) Urea [Moles/volume] in Serum or Plasma

805

3657

2.40

102.44

13.5

7.2

mmol/l

9.9

9.4

1.06

761

3500

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

965

4758

2.24

101.33

5.6

4.1

u/l

243.8

243.3

0.03

905

4500

(3044640) Blood type and Crossmatch panel - Blood

2223

14724

1.85

101.01

3.5

2.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1801

11160

1.91

100.92

3.3

2.2

—

(3032080) INR in Blood by Coagulation assay

2496

17163

1.82

100.09

11.1

8.4

inr

1.2

2.62

600

5077

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

400

1279

3.29

99.46

3.4

2.8

—

(3037467) Urinalysis macro (dipstick) panel - Urine

4036

32188

1.92

99.06

6.6

4.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

763

3453

2.40

97.64

3.5

2.6

g/l

9.9

10.5

2.89

702

3150

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2378

16246

1.81

96.29

5.2

3.4

ng/l

122.2

78.7

0.21

1665

10341

(3013826) Glucose [Moles/volume] in Serum or Plasma

3445

26265

1.82

96.23

8.8

4.4

mmol/l

6.8

6.6

6.39

3248

24298

(3036481) Cortisol [Moles/volume] in Serum or Plasma

885

4319

2.25

94.78

2.6

2.1

nmol/l

351.7

375.9

2.64

811

3960

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

601

2469

2.61

94.47

6.0

3.7

mmol/l

1.9

1.7

0.27

464

1812

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4266

34877

1.95

94.15

13.2

7.2

u/l

81.2

77.1

6.01

4043

32785

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

930

4671

2.19

92.59

2.4

1.7

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2923

21393

1.77

92.13

3.8

2.9

ug/l

129.7

107.2

2.82

2705

19894

(40768797) Stomach Pathology biopsy report

1150

6279

2.05

91.85

1.3

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

923

4641

2.18

91.56

3.2

2.5

2.0

1.8

3.20

804

4107

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

840

4066

2.25

91.53

2.9

2.2

g/l

0.2

3.03

783

3807

(3009343) pH of Capillary blood

610

2564

2.55

91.32

6.1

3.7

7.4

0.29

307

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

928

4683

2.18

91.19

2.5

1.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

613

2595

2.53

90.36

6.1

3.7

kpa

5.2

5.1

1.31

580

2409

(3028026) IgM [Mass/volume] in Serum or Plasma

625

2671

2.51

90.30

2.1

1.8

g/l

1.2

1.4

1.25

564

2438

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2572

18228

1.76

89.91

2.3

1.9

pmol/l

96.9

96.6

0.11

1414

9333

(46235355) HIV 1 and 2 tests - Meaningful Use set

1607

9894

1.88

89.86

2.3

1.9

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1226

6932

1.99

88.35

3.3

2.4

umol/l

12.0

13.3

7.79

1136

6420

(3003396) Base excess in Arterial blood by calculation

910

4618

2.16

87.89

11.6

7.2

mmol/l

1.2

1.0

0.78

732

3573

(3016502) Oxygen saturation in Arterial blood

834

4090

2.22

87.76

12.2

7.6

95.5

95.8

0.68

797

3934

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

220

506

4.48

87.68

1.9

1.4

—

(3027801) Oxygen [Partial pressure] in Arterial blood

910

4641

2.15

86.68

11.6

7.1

kpa

11.8

12.6

5.09

866

4419

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

910

4641

2.15

86.68

11.6

7.1

kpa

5.0

5.1

0.60

865

4422

(3019060) Gas panel - Arterial blood

611

2641

2.47

85.96

7.2

4.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

259

686

3.91

85.50

2.1

1.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1976

13140

1.78

84.77

2.9

2.1

u/l

161.1

203.2

1.73

1863

12300

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1632

10273

1.83

83.98

2.4

1.7

mg/l

1.1

0.60

1228

7725

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

236

593

4.11

83.77

1.9

1.4

—

(3026008) Bacteria identified in Urine by Culture

2079

14076

1.76

83.48

4.4

3.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

257

692

3.84

82.86

2.3

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1535

9522

1.84

82.58

1.7

1.4

g/l

2.4

2.3

0.38

970

5801

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2667

19455

1.71

81.16

3.0

2.2

nmol/l

78.2

77.0

1.28

2384

17549

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1127

6363

1.97

80.70

3.3

2.4

g/l

2.3

2.4

2.14

1046

5876

(3023520) Reticulocytes [#/volume] in Blood

719

3433

2.26

80.31

2.9

2.5

e9/l

73.4

70.5

1.00

547

2559

(3013707) Erythrocyte sedimentation rate by Westergren method

4144

34273

1.81

78.94

6.2

4.0

mm/h

14.4

11.7

20.15

3865

31789

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1762

11526

1.77

78.68

3.8

2.9

ng/l

1441.5

1324.7

0.53

1490

9784

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1057

5889

1.98

78.42

3.4

2.5

21.2

22.9

3.51

899

5021

(3019225) pH of Specimen

853

4429

2.09

76.80

5.1

4.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

239

647

3.81

76.43

5.0

2.7

u/ml

413.8

1487.2

0.87

(44790049)

196

465

4.33

75.03

2.2

1.4

—

(44790048)

196

465

4.33

75.03

2.2

1.4

—

(44790047)

196

465

4.33

75.03

2.2

1.4

—

(44806118)

196

465

4.33

75.03

2.2

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

348

1209

3.00

74.80

1.6

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

1119

6448

1.92

74.78

1.5

1.3

titre

482.1

558.3

0.82

248

1348

(3002032) Base excess in Venous blood by calculation

761

3825

2.15

74.45

8.1

3.6

mmol/l

2.0

1.9

0.15

638

3083

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2914

22080

1.67

74.31

5.6

4.0

—

(3012544) pH of Venous blood

779

3960

2.12

73.98

8.0

3.6

7.4

—

(3011412) CD3 cells [#/volume] in Blood

184

421

4.49

73.78

2.4

2.3

e9/l

1.2

0.36

112

250

(3021447) Carbon dioxide [Partial pressure] in Venous blood

760

3836

2.14

73.49

8.1

3.6

kpa

5.8

0.04

733

3717

(3002173) Hemoglobin [Mass/volume] in Arterial blood

753

3803

2.13

72.65

13.1

8.0

g/l

116.5

121.3

8.19

728

3656

(3021960) Folate [Moles/volume] in Serum or Plasma

1578

10189

1.77

72.57

1.7

1.5

nmol/l

20.7

20.6

0.11

1354

8725

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

187

444

4.32

71.51

2.1

1.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

144

275

5.35

71.50

2.3

1.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2157

15234

1.68

71.17

4.3

3.3

mmol/l

2.3

2.4

6.59

1841

13326

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

375

1399

2.80

70.68

3.1

2.2

ug/l

458.7

628.5

0.42

349

1303

(3014576) Chloride [Moles/volume] in Serum or Plasma

927

5131

1.97

69.28

14.0

6.6

mmol/l

103.8

104.5

4.29

912

5030

(3017143) Hepatitis C virus Ab [Presence] in Serum

1008

5761

1.92

68.42

1.9

1.6

—

(3000991) Gas panel - Venous blood

684

3423

2.14

67.28

15.4

8.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

201

529

3.90

66.87

10.1

6.5

mg/l

11.9

11.8

0.10

183

492

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

172

404

4.36

66.69

2.1

1.5

—

(3022313) Gas panel - Capillary blood

446

1873

2.50

66.18

6.3

3.8

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

447

1887

2.49

65.58

1.9

1.8

g/l

1.5

0.24

383

1632

(3015736) pH of Urine

2388

17583

1.63

65.13

5.1

3.3

—

5.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

540

2499

2.29

64.35

1.8

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

198

530

3.84

64.31

2.0

1.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

429

1800

2.50

63.72

1.7

1.6

u/ml

14.4

14.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

139

287

4.94

63.15

2.5

e9/l

0.2

0.30

118

245

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

142

301

4.81

62.53

2.4

e6/l

570.9

499.6

0.70

118

247

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

197

538

3.76

62.16

2.1

1.5

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

140

295

4.84

62.09

2.7

2.5

e6/l

725.9

736.3

0.04

123

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

399

1644

2.54

61.54

6.7

3.9

mmol/l

25.1

24.8

0.95

375

1525

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

986

5777

1.86

61.30

2.6

2.0

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

536

2522

2.24

61.27

11.0

6.7

mmol/l

24.8

24.5

1.36

506

2339

(40768804) Tissue Pathology biopsy report

2540

19183

1.60

61.01

2.5

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1073

6477

1.81

60.47

2.8

2.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

106

180

5.98

59.64

32.2

26.3

ug/l

129.4

108.6

1.69

150

(3023419) Bacteria identified in Sputum by Culture

186

508

3.75

58.68

3.9

2.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

683

3608

2.02

57.59

12.6

6.7

mmol/l

1.4

1.3

0.37

659

3473

(4010399)

617

3147

2.08

57.25

1.6

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

931

5467

1.84

57.09

4.3

33.0

32.6

0.49

623

3708

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1603

10959

1.65

57.06

1.3

u/ml

2.2

1.6

0.65

362

2929

(3048689) Calprotectin [Mass/mass] in Stool

998

5994

1.81

56.82

2.7

2.3

ug/g

138.5

121.4

0.75

787

4713

(3037692) Legionella sp identified in Specimen by Organism specific culture

127

6.86

55.44

1.7

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

640

3364

2.02

54.57

5.0

3.7

ng/l

106.4

85.8

2.00

538

2895

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

141

332

4.33

54.50

2.0

2.1

14.8

13.2

0.61

153

(3024354) Oxygen [Partial pressure] in Venous blood

608

3140

2.05

54.42

6.8

3.0

kpa

4.7

4.6

0.39

582

3030

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

647

3420

2.01

54.28

3.2

2.3

ug/l

7.5

6.6

0.35

540

2977

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1062

6589

1.76

53.82

3.0

2.1

29.6

29.7

0.15

1030

6379

(3023183) Ammonium ion [Moles/volume] in Plasma

249

861

2.98

53.80

4.5

2.7

umol/l

36.8

34.8

0.44

214

745

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

143

344

4.24

53.76

2.0

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

143

344

4.24

53.76

2.0

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

143

344

4.24

53.76

2.0

1.4

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

515

2511

2.16

53.63

14.6

8.7

1.5

1.3

2.79

510

2498

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

511

2499

2.15

52.78

14.9

8.9

0.7

1.07

506

2482

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2037

14971

1.57

52.66

5.0

3.1

u/l

36.3

33.9

0.20

1926

14208

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

135

316

4.35

52.59

2.0

2.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

117

245

4.86

52.30

3.2

2.6

35.8

41.7

1.80

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

348

1452

2.49

52.11

1.8

g/l

1.2

0.05

331

1369

(3026782) Osmolality of Urine

1314

8725

1.66

51.55

4.3

2.7

mosm/kgh2o

521.3

539.8

2.44

1155

7397

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

900

5403

1.79

50.79

12.2

6.4

—

(3028433) Virus identified in Specimen by Culture

130

6.47

50.62

1.1

1.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

160

5.83

50.53

47.0

33.7

ug/l

8.0

7.3

0.77

148

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

172

493

3.57

50.53

1.6

1.2

—

(21494815) CD4 cells/100 lymphocytes in Specimen

141

354

4.06

50.07

2.3

43.5

45.6

0.16

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

336

1406

2.48

49.98

1.8

g/l

0.2

0.39

318

1323

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3668

30859

1.55

49.92

4.7

3.0

u/l

58.3

44.2

7.98

3422

28825

(3020891) Body temperature

364

1601

2.36

48.47

7.9

4.3

—

(3018418) pH of Serum or Plasma

1815

13189

1.56

48.30

7.8

3.8

7.4

0.32

333

2506

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

324

1356

2.47

48.15

3.8

2.5

g/l

3.5

3.6

0.21

310

1281

(3020630) Protein [Mass/volume] in Serum or Plasma

626

3413

1.94

47.72

3.3

2.4

g/l

64.7

66.5

6.35

564

3121

(3018095) Leukocytes [#/volume] in Urine

2127

16039

1.53

47.62

5.9

3.6

e6/l

149.6

100.0

0.68

1571

11077

(3005322) IgE [Units/volume] in Serum or Plasma

570

3027

1.98

46.88

1.5

1.3

u/ml

199.0

193.9

0.06

528

2789

(3004119) Hemoglobin [Mass/volume] in Venous blood

490

2467

2.08

46.71

7.2

3.0

g/l

121.7

129.1

10.07

481

2399

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1383

9504

1.61

46.51

1.7

1.6

pmol/l

25722248.1

33723849.2

0.23

1143

7947

(3026493) Urate [Moles/volume] in Serum or Plasma

1602

11398

1.57

46.41

3.9

2.5

umol/l

3955.0

4436.0

0.18

1374

9913

(3027273) Bicarbonate [Moles/volume] in Venous blood

406

1910

2.21

46.06

5.3

3.2

mmol/l

25.4

25.3

0.42

394

1846

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

140

5.93

45.91

1.9

2.1

u/ml

1315.4

24374.2

0.55

(3033658) Prothrombin time (PT) actual/Normal

1597

11394

1.56

45.54

6.8

3.7

92.4

91.8

0.40

1546

11091

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

391

1833

2.22

44.71

2.7

1.8

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

218

777

2.88

44.57

1.6

1.7

—

(3013512) EKG study

1716

12495

1.54

44.41

4.9

3.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4206

36877

1.57

44.14

5.1

4.2

pmol/l

14.8

14.7

1.37

3795

33737

(3030467) Casts [#/volume] in Urine by Automated count

1699

12375

1.54

43.77

5.1

3.0

e6/l

0.4

0.34

1349

9253

(36304419) Bacteria [Presence] in Urine

1669

12132

1.54

43.30

5.0

3.0

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

276

1129

2.52

43.03

1.7

1.5

iu/ml

5.6

15.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

396

1895

2.17

42.99

1.3

u/ml

0.4

1.1

1.41

172

(40758558) Short blood count panel - Blood

1607

11615

1.54

42.67

11.7

6.7

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

391

1869

2.17

42.56

6.3

2.5

1.4

1.2

3.12

391

1854

(3035350) Ketones [Presence] in Urine by Test strip

2806

22731

1.47

42.51

5.6

3.6

estimate

0.0

1.08

482

4286

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1229

8374

1.60

42.22

1.9

1.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

150

446

3.43

41.68

2.3

1.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

358

1666

2.23

41.64

2.4

1.7

—

(3037756) Immunofixation for Serum or Plasma

215

792

2.78

41.33

1.9

1.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

298

1287

2.39

41.27

1.5

1.4

ug/g

280.8

288.2

0.23

182

715

(3000850) Epithelial cells [#/volume] in Urine

1345

9405

1.57

41.18

4.1

2.5

e6/l

6.1

6.5

0.42

1218

8192

(3006245) CD3-CD19+ cells/100 cells in Blood

174

5.06

41.06

1.8

2.2

10.0

9.2

0.24

161

(3009508) Creatinine [Moles/volume] in Urine

1796

13412

1.50

40.39

4.0

3.2

mmol/l

7.0

7.4

2.57

1481

11321

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

379

1828

2.15

40.29

6.3

2.5

0.7

0.6

0.90

371

1747

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5030

46437

1.85

40.25

29.4

13.1

mg/l

22.6

22.4

0.14

4318

36565

(3009261) Glucose [Presence] in Urine by Test strip

2822

23041

1.46

40.06

5.7

3.6

estimate

0.0

0.25

484

4294

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

319

1439

2.29

39.96

1.7

1.6

titre

343.3

385.2

0.07

(3002582) Erythrocytes [#/volume] in Urine

1797

13444

1.50

39.95

5.3

3.1

e6/l

64.7

83.5

0.39

1454

10209

(3043409) Potassium [Moles/volume] in Arterial blood

279

1191

2.41

39.65

6.9

3.8

mmol/l

3.8

3.9

0.34

271

1125

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

237

939

2.59

39.47

1.8

1.6

—

(3025941) Bacteria identified in Stool by Culture

506

2734

1.94

39.31

1.5

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

2792

22802

1.45

39.26

7.5

4.8

estimate

0.0

0.80

500

4374

(40761535) Cells panel - Urine sediment

614

3538

1.83

39.03

5.7

3.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

301

1338

2.32

39.02

5.1

3.2

u/ml

0.3

0.4

0.68

186

767

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

407

2044

2.07

38.88

10.1

4.0

mmol/l

24.0

24.2

0.34

359

1853

(3004588) Protein electrophoresis panel - Serum or Plasma

511

2790

1.92

38.45

3.1

2.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

7.63

37.75

2.5

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1474

10696

1.51

37.50

5.6

3.6

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

318

1471

2.23

37.49

1.9

2.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

225

893

2.58

37.34

1.6

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

225

893

2.58

37.34

1.6

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

631

3728

1.78

36.80

1.6

1.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

242

1005

2.47

36.51

4.5

3.4

mmol/l

24.7

24.9

0.34

226

879

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1093

7477

1.57

36.20

4.1

2.7

e6/l

1.2

0.19

650

4194

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

164

563

2.97

35.90

1.8

1.4

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

696

4259

1.72

35.83

3.1

2.3

u/l

35.1

48.5

0.61

600

3646

(3005988) Vibrio sp identified in Specimen by Organism specific culture

164

566

2.95

35.56

1.8

1.4

—

(3017181) Myelocytes/100 leukocytes in Blood

631

3767

1.76

35.44

5.4

4.1

1.0

0.9

0.74

271

1004

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

538

3063

1.84

35.42

2.1

1.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

181

4.64

35.40

1.6

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

463

2514

1.92

35.34

2.0

1.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

163

563

2.95

35.30

1.8

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

238

997

2.45

35.24

1.8

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

211

836

2.58

35.14

2.0

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1424

10377

1.50

35.09

7.1

4.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

417

2194

1.97

34.92

17.1

9.8

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

164

578

2.89

34.25

1.8

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

192

738

2.66

34.00

1.6

g/l

0.8

0.03

138

564

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4709

43104

1.60

33.81

6.3

4.9

mu/l

1.8

2.0

2.02

4299

39755

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

292

1361

2.21

33.76

1.3

u/ml

36.0

36.6

0.01

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

800

5161

1.64

33.57

4.7

2.5

umol/l

8.0

7.7

0.17

671

4443

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

161

569

2.88

33.46

1.9

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

283

1308

2.23

33.40

3.6

2.5

194.6

184.2

1.03

269

1244

(3004809) Band form neutrophils/100 leukocytes in Blood

179

670

2.73

33.40

3.8

3.2

1.4

1.5

0.21

136

519

(3024522) Salmonella sp identified in Specimen by Organism specific culture

161

570

2.88

33.35

1.9

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

101

5.89

32.99

1.3

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

300

1432

2.16

32.67

3.2

2.3

89.5

92.5

1.25

289

1327

(3028192) IgG subclass 2 [Mass/volume] in Serum

139

459

3.08

32.59

1.5

1.4

g/l

3.0

2.9

0.31

324

(3022145) Colonoscopy Study observation

774

4994

1.64

32.38

1.4

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

313

1525

2.11

32.33

1.4

1.2

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

349

1778

2.03

31.97

5.6

3.7

50.3

48.7

0.59

344

1755

(3024139) IgG subclass 3 [Mass/volume] in Serum

138

459

3.06

31.96

1.5

1.4

g/l

0.4

0.04

321

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

205

4.19

31.94

2.2

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

205

4.19

31.94

2.3

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

205

4.19

31.94

2.3

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

205

4.19

31.94

2.3

1.5

—

(3042631) Mycobacterium sp identified in Specimen

150

524

2.91

31.85

3.0

2.9

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

138

460

3.05

31.84

1.5

1.4

g/l

7.1

6.9

0.25

322

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1307

9521

1.49

31.74

1.8

1.6

—

(3012516) Albumin [Mass/volume] in Urine

1609

12212

1.45

31.57

3.9

3.3

mg/l

640.2

343.1

1.30

1055

7599

(3019150) Specific gravity of Urine by Refractometry

1339

9813

1.48

31.52

6.3

3.9

kg/l

1.0

3.24

207

1510

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

396

2120

1.93

31.45

15.7

9.2

mmol/l

24.2

24.3

0.33

360

1988

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1159

8255

1.51

31.37

1.3

iu/ml

43.2

30.0

1.45

343

2535

(3003181) Sodium [Moles/volume] in Urine

188

746

2.57

31.23

2.0

1.3

mmol/l

59.7

63.8

0.62

150

600

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

453

2553

1.84

30.68

14.1

7.1

mmol/l

24.8

0.09

448

2536

(3008757) Leukocyte morphology finding [Identifier] in Blood

134

450

3.03

30.53

3.3

3.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

162

4.55

30.51

2.4

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

162

4.55

30.51

2.4

1.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1670

12828

1.43

30.47

4.6

4.0

mg/mmol

13.9

9.2

2.33

1087

8031

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

163

4.52

30.28

2.4

1.6

—

(4062490)

135

459

2.99

30.10

1.5

1.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

246

1129

2.23

29.54

5.8

3.6

mg/l

1.7

1.5

4.03

230

1046

(3017732) Neutrophils [#/volume] in Blood

536

3214

1.74

29.41

3.3

2.8

e9/l

4.3

4.1

1.16

348

2557

(3003327) Ova and parasites identified in Stool by Light microscopy

316

1601

2.03

29.37

1.9

1.7

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

261

1230

2.18

29.35

1.4

1.3

u/ml

4.1

5.9

0.27

125

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

996

6964

1.52

29.18

4.4

2.8

e6/l

3.2

3.1

0.11

561

3702

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

263

1250

2.16

28.95

1.4

1.3

u/ml

6.0

8.3

0.40

199

(3019832) Treponema pallidum Ab [Presence] in Serum

848

5738

1.56

28.80

1.9

1.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

818

5491

1.57

28.77

1.9

1.7

1.5

1.4

4.37

702

4869

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

627

3947

1.66

28.70

2.3

1.9

—

(3042733) HLA Ab [Presence] in Serum

119

5.09

28.66

4.8

—

(3028626) Oxygen [Partial pressure] in Capillary blood

213

932

2.34

28.63

6.0

3.7

kpa

8.3

8.4

0.13

206

861

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

224

1007

2.28

28.27

1.3

u/ml

1.9

2.9

0.35

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

217

965

2.30

28.09

1.4

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

169

4.30

28.06

3.8

2.5

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

165

648

2.59

28.02

2.7

1.8

titre

2.5

3.6

—

(4035726)

621

3925

1.65

27.94

1.6

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

208

912

2.33

27.83

1.4

1.2

u/ml

305.3

265.8

1.06

135

564

(3002179) Metamyelocytes/100 leukocytes in Blood

561

3460

1.69

27.71

4.9

3.9

1.0

0.6

0.90

181

738

(3000060) B lymphocytes [#/volume] in Blood

128

4.81

27.31

1.7

2.1

e6/l

176.1

150.5

0.22

(3022217) INR in Platelet poor plasma by Coagulation assay

786

5306

1.56

26.83

26.1

23.2

inr

1.3

0.01

787

(3036489) Thrombin time

323

1705

1.95

26.70

3.0

2.1

21.4

21.3

0.06

289

1467

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

248

3.59

26.64

1.6

1.3

—

(3021901) Oxygen saturation in Capillary blood

172

707

2.48

26.57

3.8

3.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

255

3.53

26.28

1.6

1.3

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

144

547

2.68

26.16

2.1

1.6

titre

5320.0

1382.9

0.44

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

212

963

2.25

26.11

1.7

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

175

4.10

25.98

5.0

3.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

132

482

2.78

25.88

1.1

—

(1616796) Gas panel - Central venous blood

206

933

2.25

25.55

6.0

3.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

205

933

2.24

25.14

4.2

3.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

253

1252

2.07

25.07

4.4

3.1

mg/l

56.7

100.6

0.47

207

1022

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

115

397

2.94

25.02

3.1

2.8

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

247

1214

2.08

24.92

4.4

3.1

ratio

2.9

2.0

0.21

103

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

244

1197

2.09

24.75

2.0

1.6

—

(3021440) Promyelocytes/100 leukocytes in Blood

566

3600

1.64

24.72

5.2

4.1

0.2

0.25

242

935

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

252

1252

2.06

24.71

4.4

3.1

mg/l

55.0

58.3

0.09

209

1021

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

167

701

2.42

24.67

1.4

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

270

1377

2.01

24.63

1.4

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

110

374

2.98

24.59

5.1

4.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3540

31362

1.35

24.57

3.9

3.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

548

3463

1.65

24.55

3.9

2.9

ng/l

227.3

186.8

1.18

497

3136

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1101

8102

1.45

24.49

3.6

2.9

mmol/l

2.5

2.4

1.37

952

7069

(42529406) Shigella sp [Presence] in Stool by Culture

273

1401

2.00

24.47

1.5

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

193

869

2.26

24.29

1.8

1.3

u/ml

136.8

111.2

0.43

181

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1119

8278

1.44

24.16

5.1

3.6

ng/l

240.3

513.9

1.36

834

6123

(3014765) Yersinia sp identified in Stool by Organism specific culture

270

1393

1.99

23.84

1.4

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

182

3.88

23.83

1.7

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

182

3.88

23.83

1.7

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1070

7874

1.44

23.71

1.3

u/ml

14.3

11.3

0.50

362

3129

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

161

682

2.40

23.33

1.6

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

117

4.65

23.30

1.4

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

100

333

3.04

23.20

1.4

1.2

u/ml

1.3

0.8

0.40

130

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

304

1648

1.89

23.19

2.0

1.8

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

299

3.15

22.91

1.6

1.5

u/ml

24.1

20.4

0.25

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

127

4.44

22.85

3.3

2.9

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

242

1221

2.03

22.76

1.4

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

257

1329

1.98

22.55

4.6

3.2

—

(3047181) Lactate [Moles/volume] in Blood

255

1329

1.96

21.88

9.1

6.2

mmol/l

1.4

1.2

1.84

226

1162

(3019550) Sodium [Moles/volume] in Serum or Plasma

4962

46853

1.54

21.66

31.6

14.7

mmol/l

139.1

139.6

33.41

4833

45626

(3023103) Potassium [Moles/volume] in Serum or Plasma

4973

46985

1.54

21.59

31.7

14.9

mmol/l

3.9

4.0

0.28

4836

45666

(36660697) Celiac disease serology panel - Serum

596

3974

1.56

21.22

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

209

1027

2.08

21.13

1.3

u/ml

41.7

41.5

0.00

112

(4015189)

4.78

21.00

3.1

1.8

—

(3004616) Nuclear Ab [Presence] in Serum

141

592

2.42

20.87

1.4

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

112

421

2.69

20.84

3.4

3.1

61.8

57.3

0.98

273

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

303

1698

1.83

20.81

8.1

5.2

1.7

1.6

0.18

282

1583

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

333

1921

1.78

20.78

2.2

1.9

u/l

42.3

39.1

1.88

299

1727

(1761868) Lipid panel - Serum or Plasma

1301

16369

0.73

20.51

2.8

2.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

494

3181

1.61

20.40

3.3

pmol/l

4.3

4.5

3.64

417

2833

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

533

3495

1.58

20.38

3.1

2.6

ml/min/173m2

64.5

67.8

1.02

252

1381

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

5.72

20.20

1.5

1.9

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

314

1796

1.79

20.16

1.6

1.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

299

1686

1.82

20.13

8.2

5.3

0.9

0.69

280

1576

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

131

541

2.46

20.12

1.3

1.2

—

(40768443) Skin Pathology biopsy report

339

1990

1.75

19.91

1.3

1.2

—

(3042517) Benzodiazepines panel - Urine

7.28

19.90

3.6

2.3

—

(3016038) Potassium [Moles/volume] in Urine

277

3.06

19.87

1.8

1.2

mmol/l

30.7

34.7

0.99

239

(3008295) Osmolality of Serum or Plasma

117

461

2.57

19.84

1.4

mosm/kgh2o

282.6

278.3

1.07

357

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

262

3.12

19.80

1.5

1.1

—

(3025159) Blasts/100 leukocytes in Blood

517

3397

1.58

19.57

5.1

4.1

0.0

0.3

1.02

194

790

(3024471) HLA-A [Type]

122

4.21

19.48

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

239

3.21

19.48

2.0

1.4

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

260

3.11

19.41

1.2

1.4

titre

80.0

66.0

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

205

3.40

19.37

3.7

1.7

umol/l

2.1

1.9

0.56

193

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

6.14

19.35

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

175

833

2.14

19.26

5.1

2.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2087

17543

1.30

18.99

6.2

3.7

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

263

1452

1.85

18.96

1.7

1.6

iu/ml

1.1

4.6

0.41

304

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

135

584

2.34

18.73

2.7

2.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

187

923

2.06

18.71

2.7

2.1

g/l

123.9

128.4

1.59

127

665

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

6.07

18.55

2.8

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

174

844

2.10

18.25

1.6

1.5

—

(3024928) Oxygen saturation in Venous blood

178

872

2.08

18.19

8.9

2.8

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

165

3.60

18.17

2.7

1.9

ug/l

78.8

58.9

0.69

158

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

209

3.28

18.11

2.1

1.5

—

(3024932) HLA-DR beta [Type]

121

4.08

17.97

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

211

3.25

17.84

2.1

1.5

—

(3011288) Drugs identified in Urine by Screen method

240

1314

1.86

17.78

5.8

2.7

—

(3037121) Protein [Mass/volume] in Urine

269

1526

1.80

17.77

4.0

3.1

g/l

0.6

0.3

1.10

142

611

(3039000) Anion gap in Blood

185

933

2.02

17.48

10.9

7.3

mmol/l

11.5

11.2

0.67

168

831

(3018572) Chloride [Moles/volume] in Blood

185

934

2.01

17.42

10.9

7.3

mmol/l

104.1

105.3

2.17

168

832

(3042111) Morphology [Interpretation] in Bone marrow Narrative

147

682

2.19

17.30

2.3

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

171

3.48

17.24

2.2

2.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

230

1259

1.86

17.06

1.3

1.2

titre

182.1

96.2

0.62

109

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

273

1575

1.77

17.04

1.5

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

484

3232

1.54

17.00

1.3

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

374

2351

1.63

16.99

2.5

2.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

109

448

2.46

16.97

1.3

1.2

u/l

61.6

58.7

0.15

307

(3035637) Corticotropin [Mass/volume] in Plasma

128

566

2.29

16.92

1.8

1.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

101

4.28

16.85

1.1

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

158

762

2.10

16.85

1.2

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

132

3.81

16.76

1.8

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

267

2.91

16.74

2.8

1.4

umol/l

14.4

23.1

3.43

255

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

220

1195

1.88

16.72

2.2

2.0

mg/l

11.5

11.4

0.09

206

1105

(1001926) Buprenorphine [Presence] in Urine by Screen method

261

1497

1.78

16.62

4.3

2.0

—

(3016879) Cocaine [Presence] in Urine

298

1777

1.72

16.56

4.3

2.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

239

1340

1.82

16.42

1.4

—

(40768446) Kidney Pathology biopsy report

167

3.44

16.40

2.2

1.6

—

(3032057) Clostridioides difficile [Presence] in Stool

4.51

16.31

2.3

1.9

—

(3000492) Spirometry study

618

4379

1.46

16.27

1.7

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

172

868

2.01

16.24

3.8

2.3

15.4

16.2

1.65

428

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

272

1590

1.75

16.23

3.1

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

272

1591

1.75

16.19

3.1

2.3

g/l

7.5

7.4

0.25

193

1199

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

257

1480

1.77

16.15

3.2

2.3

g/l

9.8

10.2

0.64

200

1255

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

363

2.59

16.15

1.2

u/ml

92.3

54.9

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

155

756

2.08

16.06

1.2

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

620

4408

1.46

16.03

3.7

3.9

ug/l

17.5

29.0

0.59

502

3490

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4407

41240

1.33

15.84

7.1

5.4

mmol/mol

40.7

39.2

13.49

4034

38235

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

121

539

2.27

15.75

2.2

2.1

mg/l

25.6

22.3

0.19

140

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

270

1590

1.73

15.70

3.1

2.3

g/l

3.7

3.8

0.54

182

1144

(3019420) Tryptase [Mass/volume] in Serum or Plasma

263

2.84

15.42

1.3

1.5

ug/l

7.4

0.00

228

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

308

2.69

15.39

2.2

1.5

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

366

2.54

15.38

1.2

u/ml

34.5

42.3

0.15

(3029937) Albumin [Presence] in Urine by Test strip

1486

12201

1.30

15.38

6.9

3.9

estimate

0.0

1.70

479

4273

(3016228) CD19 cells/100 cells in Blood

180

3.25

15.27

2.2

2.0

6.5

8.9

1.11

171

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

127

586

2.19

15.19

1.0

1.1

g/l

1.5

0.13

109

534

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

255

1496

1.74

15.04

3.2

2.3

g/l

3.1

0.36

184

1174

(3051651) Icteric interference index of Serum or Plasma

267

2.80

15.00

6.6

3.6

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5108

49056

1.49

14.96

17.3

9.9

u/l

25.2

25.4

0.53

4944

47316

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

195

1057

1.88

14.95

1.3

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

308

1906

1.65

14.90

4.4

2.0

—

(3028300) Cannabinoids [Presence] in Urine

310

1928

1.64

14.70

4.3

1.9

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

394

2.44

14.57

1.2

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

386

2.43

14.24

1.2

1.1

—

(3027008) Opiates [Presence] in Urine

307

1923

1.63

14.16

4.3

1.9

—

(3012501) Base excess in Blood by calculation

179

961

1.89

14.15

7.9

3.9

mmol/l

2.8

2.6

0.27

135

636

(3013290) Carbon dioxide [Partial pressure] in Blood

179

961

1.89

14.15

7.9

3.9

kpa

5.0

0.35

174

945

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

352

2.49

14.08

1.2

1.3

mmol/l

2.3

2.0

0.90

329

(3027315) Oxygen [Partial pressure] in Blood

179

965

1.88

13.98

7.9

3.9

kpa

8.7

0.12

174

948

(21494890) Protein electrophoresis panel - 24 hour Urine

402

2.39

13.95

2.3

1.9

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

144

723

2.02

13.85

1.2

u/ml

3.4

4.7

0.92

300

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

296

2.62

13.84

1.6

1.3

—

(3014271) Vancomycin [Susceptibility]

208

2.95

13.73

3.7

2.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

220

1275

1.76

13.57

1.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

133

656

2.05

13.44

2.9

1.7

mmol/l

1.5

1.7

1.22

128

639

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

349

2.46

13.35

1.2

u/ml

4.0

6.2

0.27

(3027944) Amphetamines [Presence] in Urine

299

1889

1.62

13.33

3.8

1.9

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

230

1363

1.72

13.12

3.3

2.3

g/l

0.8

0.9

0.19

197

1181

(3052592) Norovirus Ag [Presence] in Stool

4.40

13.06

1.6

1.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

437

3019

1.49

13.03

1.3

au/ml

45.1

49.6

—

123

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

220

2.84

13.01

2.3

1.9

156.6

139.4

0.73

210

(3022493) Free Hemoglobin [Mass/volume] in Plasma

167

3.13

12.99

6.1

5.4

mg/l

54.1

61.6

0.59

116

(3010421) pH of Blood

198

1129

1.78

12.93

8.0

3.8

7.4

0.06

174

945

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

469

3299

1.46

12.75

2.5

2.4

au/ml

14.9

23.1

1.49

208

(3009214) Lutropin [Units/volume] in Serum or Plasma

228

1364

1.70

12.57

1.4

1.3

u/l

13.4

10.7

1.30

170

1133

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

136

3.33

12.42

2.2

2.0

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

122

605

2.04

12.19

1.3

u/ml

42.0

55.8

0.33

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4551

43168

1.30

12.13

21.8

12.1

ml/min/173m2

83.4

83.2

0.16

3817

35458

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

167

924

1.83

12.07

4.9

3.5

57.9

57.3

0.21

167

924

(3051611) Lipemic interference index of Serum or Plasma

449

2.20

12.02

5.7

3.3

—

(40761511) CBC panel - Blood by Automated count

5033

48468

1.39

11.89

25.2

12.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

107

510

2.12

11.89

1.6

1.5

g/l

31.3

32.3

0.29

463

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

198

2.85

11.87

1.8

2.0

umol/l

103.5

148.2

0.60

107

(3017315) Amylase [Enzymatic activity/volume] in Urine

216

2.75

11.72

1.2

u/l

215.8

308.9

0.63

201

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

134

699

1.94

11.62

1.1

116.3

116.6

0.04

122

626

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

383

2637

1.49

11.61

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

317

2.42

11.59

1.3

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

163

3.02

11.57

1.4

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

179

1026

1.77

11.52

1.4

1.3

mmol/l

3.9

3.7

1.18

162

957

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

8.35

11.48

2.4

2.1

—

(3048879) Bone marrow aspiration report

104

3.57

11.42

2.2

1.9

—

(40757494) Bilirubin.total [Moles/volume] in Blood

225

2.68

11.40

2.6

umol/l

21.5

22.5

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

5.90

11.31

1.7

1.6

mg/l

3.6

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

130

680

1.93

11.20

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

262

2.54

11.20

1.1

1.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

196

1165

1.71

11.11

1.4

1.3

mg/l

617.5

504.2

0.38

184

1101

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

105

511

2.07

11.07

1.1

90.1

95.9

1.34

481

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

174

2.89

10.93

4.4

4.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.65

10.92

14.0

13.0

mmol/l

5.7

6.1

0.19

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

138

743

1.88

10.91

1.2

u/ml

3.7

3.8

0.05

244

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

302

2.40

10.88

1.2

1.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

207

1257

1.67

10.84

3.0

2.1

g/l

36.4

37.7

1.85

172

1080

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

346

2.30

10.83

1.3

1.2

titre

92.6

181.4

1.61

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

4.19

10.79

2.4

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

316

2.36

10.75

1.3

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

167

959

1.76

10.71

1.6

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

350

2407

1.48

10.68

2.7

2.2

u/l

5520.9

5509.5

0.00

137

978

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

305

2.38

10.65

1.2

1.0

—

(4306422)

135

729

1.87

10.59

1.2

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

282

2.43

10.54

15.2

11.9

mmol/l

0.7

0.6

0.83

258

(3006922) Hepatitis E virus Ab [Presence] in Serum

320

2.33

10.46

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

117

606

1.95

10.40

6.1

5.3

umol/l

341.1

364.9

0.90

101

529

(3004716) Salmonella sp identified in Stool by Organism specific culture

367

2562

1.46

10.39

1.6

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.17

10.33

2.1

1.5

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

295

1974

1.52

10.28

1.1

u/ml

1.0

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

493

3637

1.39

10.26

1.2

iu/ml

106.5

154.5

2.23

170

1365

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

228

2.56

10.08

1.7

1.8

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

320

2.30

10.02

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

153

877

1.77

9.90

1.4

1.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

367

2.20

9.86

1.2

1.3

nmol/l

1.5

0.05

331

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

304

2.32

9.82

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

420

2.11

9.82

1.4

1.5

—

(3017704) Immunofixation for Urine

220

2.56

9.75

1.9

1.6

—

(3049717) Cytology report of Urine Cyto stain

223

1418

1.60

9.75

2.7

2.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

590

4515

1.34

9.74

5.2

3.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

137

767

1.81

9.61

1.2

1.1

au/ml

21.1

11.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

138

776

1.80

9.54

2.2

2.1

umol/l

5.7

7.0

0.51

565

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

247

2.44

9.49

1.4

1.2

u/l

49.5

18.7

2.09

212

(21494434) Karyotype in Bone marrow

354

2.19

9.45

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

272

2.37

9.44

1.7

1.5

u/l

6.8

5.8

0.15

130

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

400

2.12

9.44

1.3

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

5.47

9.44

1.7

1.6

mg/l

4.5

2.6

0.61

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

5.47

9.44

1.7

1.6

mg/l

1.0

0.9

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

5.47

9.44

1.7

1.6

mg/l

3.5

1.5

0.42

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

5.47

9.44

1.7

1.6

mg/l

1.9

0.7

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

5.47

9.44

1.7

1.6

mg/l

3.7

1.2

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

5.47

9.44

1.7

1.6

mg/l

3.4

2.2

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

5.47

9.44

1.7

1.6

mg/l

2.2

1.9

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

5.47

9.44

1.7

1.6

mg/l

4.5

3.7

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

5.47

9.44

1.7

1.6

mg/l

1.8

0.6

—

(3006653) Thiamine [Moles/volume] in Blood

230

2.49

9.41

1.3

nmol/l

133.6

133.3

0.01

230

(3021387) Prolactin [Units/volume] in Serum or Plasma

287

1947

1.50

9.39

1.7

1.6

mu/l

353.2

300.5

1.09

249

1739

(3023199) Leukocytes [#/volume] in Pleural fluid

469

2.02

9.34

1.7

1.4

e6/l

5410.6

1869.8

0.49

345

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.95

9.30

6.4

6.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

218

1398

1.58

9.22

1.1

u/ml

5.6

6.1

0.10

179

(4268621)

499

1.98

9.20

2.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

216

2.51

9.09

1.9

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

216

2.51

9.09

1.9

1.6

—

(3036603) Volume of Urine

277

2.33

9.08

1.9

1.5

2143.2

1996.5

0.12

(3028308) Erythrocytes [#/volume] in Pleural fluid

417

2.05

8.86

1.7

1.4

e6/l

30751.9

75830.0

1.14

241

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

256

2.36

8.80

1.5

1.2

u/l

115.0

79.6

2.10

224

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

180

1118

1.63

8.71

3.2

2.2

g/l

0.0

0.50

166

1029

(40765096) Chromosome analysis panel by Banding

130

2.94

8.63

1.1

—

(4146454)

442

2.01

8.61

2.6

2.7

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

107

575

1.88

8.60

2.7

2.5

u/ml

230.1

828.2

0.55

527

(3047189) Immunofixation for 24 hour Urine

187

2.58

8.55

1.7

1.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

178

1108

1.63

8.54

3.2

2.2

g/l

0.0

0.00

165

1028

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

190

1203

1.60

8.51

3.2

2.2

g/l

0.0

0.45

176

1109

(3020191) Ethanol [Moles/volume] in Serum or Plasma

338

2.14

8.44

1.7

1.4

promille

1.2

0.04

267

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

124

702

1.78

8.43

1.1

—

(40768441) Liver Pathology biopsy report

325

2.17

8.43

1.6

1.4

—

(3007463) Buprenorphine [Presence] in Urine

7.51

8.41

13.2

3.9

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

7.51

8.41

3.6

4.8

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

7.51

8.41

3.6

4.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

225

2.41

8.37

1.2

1.1

u/l

37.3

25.3

0.45

166

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

201

2.50

8.36

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

195

1248

1.58

8.35

1.5

1.3

—

(3012441) Differential panel - Pleural fluid

386

2.06

8.35

1.6

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

244

2.35

8.32

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

226

2.40

8.29

1.2

1.1

u/l

100.0

80.1

0.85

171

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

4.09

8.24

1.1

1.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

119

673

1.78

8.14

1.8

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.91

8.13

1.1

1.0

—

(3045142) Bone marrow Pathology biopsy report

459

1.95

8.11

1.4

1.3

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

324

2.14

8.10

2.6

1.8

mg/l

5.0

4.1

0.48

311

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

175

2.58

8.06

1.2

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.27

7.92

1.3

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

5.17

7.92

1.3

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

143

859

1.68

7.91

3.4

3.3

u/ml

1208.3

654.3

0.27

126

785

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.63

7.86

1.3

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

113

641

1.78

7.67

1.4

1.2

u/l

39.4

38.3

0.04

554

(3023323) Follitropin [Units/volume] in Serum or Plasma

349

2556

1.39

7.62

1.5

1.3

iu/l

27.7

25.9

0.41

279

2191

(40761539) Cells [Type] in Urine sediment by Light microscopy

102

3.05

7.56

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

304

2177

1.42

7.56

4.0

2.7

e6/l

0.4

0.3

0.80

296

2115

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

124

2.83

7.51

1.4

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

141

2.71

7.49

2.0

1.9

mg/l

9.6

9.4

0.06

114

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

108

2.97

7.48

1.6

1.7

au/ml

314.2

102.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

343

2517

1.39

7.41

2.6

2.1

nmol/l

11.6

11.9

0.23

294

2206

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

5.92

7.37

5.5

5.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

372

2.00

7.29

1.3

1.2

—

(3011985) Renin [Units/volume] in Plasma

101

564

1.81

7.25

2.4

1.5

mu/l

85.8

52.1

0.42

498

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

3.16

7.24

10.9

7.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

167

2.53

7.23

1.2

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

113

653

1.75

7.23

1.3

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

4463

42844

1.21

7.19

27.8

14.2

38.6

39.6

9.99

3016

31688

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

261

2.20

7.17

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

125

745

1.69

7.16

3.8

3.1

nmol/l

0.9

0.8

0.29

567

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

205

2.35

7.10

7.9

6.1

u/ml

39.8

101.3

0.73

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

119

702

1.71

7.08

1.2

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4573

44021

1.22

7.06

5.3

4.3

mmol/l

6.0

5.9

9.17

4122

40281

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

270

2.16

7.01

1.3

umol/l

4.6

5.1

0.51

251

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

330

2.04

7.00

1.6

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

293

2.09

6.82

3.3

mu/l

37.6

26.8

0.93

281

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.10

6.80

1.3

1.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

5.43

6.76

1.2

1.0

—

(3002256) Pathology report gross observation

733

6042

1.25

6.75

1.4

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

122

735

1.67

6.74

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

150

952

1.59

6.73

2.6

2.4

ug/min

77.3

91.7

0.30

573

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

135

835

1.63

6.73

1.3

1.4

u/l

26.5

25.8

0.08

101

703

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

7.15

6.69

2.9

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.99

6.64

1.1

umol/24h

0.6

0.7

—

(3017569) Oxygen content in Arterial blood

193

2.34

6.62

2.0

2.3

—

(40768806) Pleura Pathology biopsy report

394

1.92

6.55

1.7

1.6

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

265

2.12

6.52

1.3

1.6

u/l

5.5

6.5

0.65

225

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

5.21

6.48

1.1

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

101

2.88

6.46

1.1

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.55

6.45

1.2

—

(3025130) Human papilloma virus identified in Specimen

127

784

1.63

6.40

1.7

—

(3044927) Protein electrophoresis panel - Urine

412

1.88

6.38

1.3

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

106

625

1.71

6.36

1.3

nmol/l

0.3

—

(40757373) Influenza virus identified in Isolate

3.03

6.33

1.9

1.5

—

(3045424) Erythrocytes [Presence] in Urine

125

771

1.64

6.33

1.7

1.5

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

119

2.70

6.32

1.3

1.4

nmol/l

130.9

132.3

0.01

(3035947) Staphylolysin Ab [Units/volume] in Serum

191

2.31

6.31

1.2

1.1

iu/ml

3.6

3.8

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.10

6.30

1.5

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.10

6.30

1.5

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.10

6.30

1.5

1.1

—

(4198724)

205

2.25

6.22

3.0

1.8

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

264

2.09

6.19

1.3

u/l

12.0

11.4

0.12

242

(3004451) EKG impression Narrative

193

2.29

6.17

1.5

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.76

6.08

1.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

234

2.15

6.02

1.6

1.5

nmol/l

1.5

1.2

0.90

181

(3021589) Normoblasts [#/volume] in Blood

2237

20512

1.15

6.00

16.6

9.0

e9/l

0.0

0.08

1854

16726

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.46

6.00

1.5

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.87

5.98

3.0

2.1

—

(3025315) Body weight

4.52

5.98

5.7

4.3

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

141

2.49

5.92

1.4

1.5

55.1

65.0

0.81

114

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

229

2.15

5.92

1.5

1.6

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

172

2.33

5.89

1.1

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

154

2.41

5.85

2.6

2.8

mg/l

8.2

7.9

0.11

122

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

154

2.41

5.85

1.2

87.5

87.9

0.02

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

460

3651

1.28

5.83

7.1

3.4

mmol/l

1.2

0.96

409

3159

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

131

836

1.58

5.80

4.9

2.6

—

(4034850)

205

1440

1.44

5.75

12.6

9.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

5.01

5.74

1.2

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1408

12518

1.17

5.67

5.1

3.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

5.89

5.62

6.9

8.8

—

(37021550) Renin [Units/volume] in Plasma --upright

2.74

5.51

1.8

1.3

mu/l

47.0

57.4

0.24

(3016018) Differential panel - Cerebral spinal fluid

500

1.73

5.48

1.6

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

171

1173

1.47

5.45

1.3

1.2

—

(3006576) Bicarbonate [Moles/volume] in Blood

129

2.49

5.43

8.2

6.1

mmol/l

23.8

24.3

0.20

118

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

570

1.68

5.41

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.96

5.40

10.7

7.8

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

128

829

1.56

5.35

2.1

2.0

nmol/l

0.9

0.8

0.84

103

699

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

168

2.27

5.28

1.2

g/l

0.3

1.46

136

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

5.01

5.25

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

149

1004

1.50

5.20

1.8

1.7

e6/l

19983.4

11499.0

1.02

118

725

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.64

5.19

1.0

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.69

5.16

1.1

79.8

77.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

472

1.73

5.15

10.6

5.7

mmol/l

7.3

7.1

0.23

387

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

232

1701

1.38

5.13

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

139

2.38

5.12

1.0

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

139

2.38

5.12

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

223

2.07

5.11

2.4

1.7

u/field

1.6

3.5

1.01

156

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

231

1696

1.38

5.07

1.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

224

2.06

5.06

1.1

u/ml

4.1

6.0

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

3.08

5.06

1.4

1.5

nmol/l

4.3

511545.3

0.71

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

307

1.90

5.05

1.1

iu/ml

7.4

9.6

0.32

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

232

1707

1.37

5.03

1.3

miu/ml

202.7

229.1

0.49

830

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

373

1.81

4.98

2.7

1.7

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

150

1022

1.48

4.98

1.6

1.4

e6/l

82.7

28.4

0.31

123

764

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

150

1022

1.48

4.98

1.7

1.4

e6/l

129.1

4807.9

0.70

128

816

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

160

2.26

4.97

1.2

1.1

87.2

88.5

0.09

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

105

2.58

4.95

1.6

1.1

pmol/l

270.8

275.4

0.03

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

231

1703

1.37

4.95

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

231

1704

1.37

4.94

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.67

4.90

1.4

1.2

—

(3011648) Oxygen content in Venous blood

340

1.83

4.85

3.8

2.1

10.7

11.2

0.37

340

(3035880) pH of Pleural fluid

215

2.05

4.81

1.3

1.4

—

(3006270) Folate [Moles/volume] in Blood

407

1.75

4.81

1.3

1.1

nmol/l

355.5

375.4

0.32

364

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.58

4.76

1.0

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

2.88

4.75

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

379

1.78

4.75

1.7

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.41

4.74

1.3

1.4

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

103

2.53

4.62

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

103

2.53

4.62

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

103

2.53

4.62

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

103

2.53

4.62

1.1

—

(3003694) ABO and Rh group [Type] in Blood

1512

13690

1.14

4.59

1.6

1.5

—

(3019977) pH of Arterial blood

206

2.05

4.56

2.5

2.8

7.4

0.17

(3002523) Influenza virus A Ag [Presence] in Specimen

119

788

1.52

4.56

1.2

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.41

4.56

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.56

4.54

1.1

71.8

69.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

262

1.92

4.52

1.1

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

136

2.29

4.44

1.5

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

301

1.84

4.37

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

118

788

1.51

4.37

1.2

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

203

2.03

4.36

3.0

2.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

122

821

1.50

4.35

1.1

u/ml

0.8

1.7

0.87

211

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

7.51

4.35

1.0

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.73

4.34

1.6

1.3

mmol/l

1.5

1.7

0.22

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

119

2.36

4.31

1.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

171

2.11

4.27

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

599

5071

1.20

4.24

1.5

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

120

2.34

4.24

1.0

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

378

1.73

4.23

2.0

1.4

30.2

33.2

0.30

230

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

114

2.37

4.22

1.6

ug/l

0.3

0.4

0.41

(3001893) Eosinophils/100 leukocytes in Pleural fluid

114

2.37

4.22

1.3

1.6

2.0

3.3

0.56

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.56

4.21

1.2

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

3.62

4.20

1.2

1.1

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.91

4.16

1.1

1.2

u/ml

0.0

0.5

0.51

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

534

1.60

4.14

1.3

pmol/l

412.6

352.1

0.30

416

(3025018) Bordetella pertussis Ab [Titer] in Serum

278

1.84

4.12

1.3

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

201

1497

1.36

4.10

3.3

3.4

u/ml

151.6

3022.5

0.90

167

1258

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

141

2.21

4.10

2.3

2.4

au/ml

212.0

130.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

104

687

1.52

4.07

1.2

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.86

4.05

2.2

1.6

pmol/l

57.2

38.8

0.39

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

107

716

1.50

3.96

1.1

iu/ml

80.1

789.0

0.50

176

(3026692) Albumin [Mass/volume] in Peritoneal fluid

106

2.36

3.89

1.3

1.5

g/l

10.2

12.7

0.63

(3008898) HLA-B27 [Presence]

234

1801

1.31

3.84

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

2.97

3.84

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

249

1.85

3.83

2.7

1.9

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

123

853

1.45

3.82

1.5

nmol/l

0.4

0.35

691

(3007461) Platelets [#/volume] in Blood

5241

51632

1.25

3.81

39.9

19.5

e9/l

259.1

255.9

2.63

5130

50380

(3023430) Cat dander IgE Ab [Units/volume] in Serum

650

1.52

3.79

1.2

1.1

u/ml

4.1

3.5

0.11

270

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

140

996

1.42

3.79

1.2

1.1

u/ml

1.1

1.3

0.13

396

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

114

2.29

3.77

1.2

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.73

3.75

1.8

1.2

ng/l

56.7

65.7

0.08

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

115

2.27

3.70

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.01

3.68

1.0

1.1

—

(1002224) Polysomnography panel

236

1833

1.30

3.64

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

5243

51676

1.24

3.64

40.1

19.6

g/l

130.4

134.4

69.80

5175

50981

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.67

3.63

1.3

—

(3024731) MCV [Entitic volume]

5241

51657

1.24

3.62

39.7

19.4

91.0

90.8

2.05

5172

50964

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

404

1.64

3.61

1.3

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1386

0.67

3.61

1.9

1.8

—

(3035941) MCH [Entitic mass]

5241

51659

1.24

3.60

39.6

19.4

30.2

0.98

5173

50962

(3010144) Erythrocytes [#/volume] in Synovial fluid

389

1.65

3.60

1.4

e6/l

76854.1

77768.8

0.00

263

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.75

3.58

3.2

2.8

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

143

2.10

3.58

1.1

—

(21494755) Public health laboratory ask at order entry panel

387

4660

0.82

3.58

1.3

—

(3026361) Erythrocytes [#/volume] in Blood

5241

51664

1.24

3.56

39.9

19.5

e12/l

4.4

4.5

49.90

5125

50275

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

476

1.58

3.55

1.0

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

492

1.57

3.55

1.9

1.6

60.9

58.3

0.26

308

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

237

1850

1.29

3.53

1.7

mg/l

6.5

3.9

1.33

171

1297

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.85

3.52

1.2

1.0

—

(3010813) Leukocytes [#/volume] in Blood

5241

51674

1.24

3.49

39.9

19.5

e9/l

7.1

6.7

17.37

5125

50273

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.70

3.48

1.5

1.3

mmol/l

1.6

1.5

0.01

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

125

2.17

3.47

2.1

2.0

e6/l

11674.3

20443.6

0.20

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

141

1022

1.39

3.46

1.8

1.7

nmol/l

49.2

42.2

1.56

134

986

(3023487) Leukocytes [#/volume] in Peritoneal fluid

145

2.07

3.46

2.3

2.4

e6/l

419.6

863.7

1.17

108

(3021788) Differential panel - Synovial fluid

110

764

1.45

3.43

1.7

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

114

798

1.44

3.41

1.1

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

216

1.86

3.39

1.8

1.6

nmol/l

4.8

6.6

0.25

173

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.83

3.35

2.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

127

2.13

3.35

1.0

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

182

1.93

3.32

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

377

1.62

3.25

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

377

1.62

3.25

1.2

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1293

11817

1.12

3.25

1.8

1.6

mmol/l

1.5

1.4

4.11

1128

9975

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.03

3.24

1.1

1.0

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

378

1.62

3.22

1.2

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

355

1.64

3.21

1.1

1.0

mg/l

292.8

289.6

0.11

320

(3008401) Mugwort IgE Ab [Units/volume] in Serum

120

861

1.40

3.16

1.1

u/ml

0.8

1.3

0.71

378

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

380

1.61

3.16

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

380

1.61

3.16

1.2

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

356

4265

0.82

3.15

1.6

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

381

1.61

3.13

1.2

1.1

—

(40762365) Oxygen content in Arterial blood by calculation

2.47

3.12

2.6

2.5

ml/dl

15.1

14.7

0.23

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

4.51

3.11

1.4

2.5

—

(3009871) Measles virus Ab [Titer] in Serum

145

2.01

3.09

1.4

1.7

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

187

1.88

3.09

1.0

1.1

ng/l

386.6

355.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.33

3.07

1.3

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

5.01

3.05

3.3

2.9

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

2.75

2.98

1.0

u/ml

0.6

1.0

—

(3017509) Phencyclidine [Presence] in Urine

2.75

2.98

3.6

1.4

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

2.75

2.98

1.0

u/ml

0.0

0.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

2.75

2.98

1.0

u/ml

0.1

0.9

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

147

1104

1.34

2.95

1.5

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

184

1.85

2.91

5.7

10.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

288

1.67

2.90

1.4

1.2

—

(3034426) Prothrombin time (PT)

170

1.89

2.89

1.1

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

4.10

2.88

1.9

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.43

2.87

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

5.39

2.86

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

164

1258

1.31

2.85

1.6

1.9

iu/l

3.7

4.5

0.68

465

(3045462) Protein/Creatinine [Ratio] in Urine

2.77

2.81

5.5

6.0

g/mol

31.8

52.0

0.42

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

2.65

2.79

1.0

u/ml

0.0

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.55

2.78

1.5

1.4

nmol/l

0.3

0.4

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

3.92

2.77

1.4

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.27

2.76

1.0

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

347

1.59

2.75

2.1

u/field

1.1

1.9

1.12

136

(3040893) Potassium [Moles/volume] in Capillary blood

5.00

2.72

3.7

2.7

mmol/l

4.0

4.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.98

2.69

3.5

1.5

umol/l

55.3

43.1

0.34

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.98

2.69

19.2

9.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

312

1.61

2.63

1.0

1.1

u/ml

4.1

1.4

0.34

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

407

1.53

2.63

1.1

1.4

mmol/l

11.8

12.0

0.09

(3033799) Differential panel - Peritoneal fluid

120

2.00

2.60

2.1

2.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

330

2776

1.20

2.59

3.2

3.3

u/ml

62.1

52.9

0.19

314

2679

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

127

1.97

2.59

1.0

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

4.67

2.59

2.3

2.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

121

902

1.35

2.59

1.1

u/ml

3.1

5.8

1.36

478

(3044242) Glucose [Moles/volume] in Arterial blood

199

1.76

2.59

2.0

2.1

—

(40768795) Lymph node Pathology biopsy report

441

1.50

2.58

1.3

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.60

2.57

1.0

1.7

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.60

2.57

1.0

1.7

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3.60

2.57

1.0

—

(3036180) Methadone [Presence] in Urine

7.15

2.55

2.2

3.3

—

(3020393) Adenovirus Ag [Presence] in Stool

2.73

2.54

2.0

1.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.42

2.53

1.0

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

584

1.43

2.51

1.1

1.0

u/ml

0.1

0.3

1.35

142

(3044941) Cell count panel - Synovial fluid

668

1.40

2.51

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

226

1837

1.24

2.51

1.5

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

137

1.90

2.45

1.5

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

110

2.00

2.40

3.0

2.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

110

2.00

2.40

3.0

2.7

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

5.00

2.40

1.2

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

466

1.46

2.38

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

226

1849

1.23

2.38

1.4

1.5

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

6.25

2.37

5.8

8.9

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

442

1.48

2.37

1.2

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.42

2.36

1.2

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

639

5715

1.13

2.30

2.0

1.8

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

192

1.72

2.29

2.0

1.4

3.9

3.8

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

200

1.70

2.27

1.1

1.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

2.46

2.27

1.2

1.7

9.0

7.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

293

1.57

2.27

1.1

nmol/l

3.3

12.7

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.89

2.25

3.7

2.7

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.89

2.25

1.9

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

255

1.61

2.23

1.0

1.1

u/ml

4.4

23.6

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4403

43122

1.10

2.22

4.4

3.7

mmol/l

1.3

4.20

3971

39649

(3035285) Chloride [Moles/volume] in Venous blood

490

1.43

2.22

4.1

2.2

mmol/l

105.3

105.4

0.05

483

(3041354) Potassium [Moles/volume] in Venous blood

490

1.43

2.22

4.1

2.2

mmol/l

4.1

4.0

0.12

483

(3023410) Appearance of Cerebral spinal fluid

482

1.44

2.21

2.0

1.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.05

2.21

2.5

2.3

umol/l

16.1

16.5

0.07

(3013293) Extractable nuclear Ab [Presence] in Serum

2.20

1.6

1.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

702

1.36

2.20

1.2

1.1

u/ml

4.9

3.4

0.26

275

(3033705) Calcium.ionized [Moles/volume] in Venous blood

478

1.43

2.12

4.2

2.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.37

2.12

1.3

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

5.00

2.07

6.2

4.4

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.91

2.07

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

309

1.53

2.05

1.0

1.1

u/ml

0.4

2.2

0.95

102

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.98

2.05

2.2

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

184

1.69

2.03

1.5

pmol/l

14.9

14.4

0.28

154

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

730

1.33

2.02

1.1

1.0

u/ml

2.3

3.3

0.65

338

(3044007) Cell count panel - Peritoneal fluid

118

1.87

2.01

2.6

2.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

111

853

1.31

2.01

1.3

ug/l

2.5

3.7

2.45

103

773

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

409

1.45

2.00

1.2

1.1

mg/l

42.9

39.0

0.19

339

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.82

2.00

5.4

4.5

—

(3020491) Glucose [Moles/volume] in Blood

368

1.47

1.99

2.0

1.8

mmol/l

7.2

6.4

0.69

255

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.96

1.99

1.4

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

134

1057

1.27

1.99

6.0

4.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

377

1.46

1.98

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

272

1.55

1.97

1.0

u/ml

0.3

2.6

—

(3045716) Anion gap in Serum or Plasma

194

1.65

1.95

2.5

2.1

mmol/l

8.2

9.5

1.48

152

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4655

45784

1.10

1.94

5.3

4.6

mmol/l

2.7

2.8

22.78

4224

42337

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1177

0.75

1.94

1.5

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

4.55

1.94

1.6

1.3

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

4.55

1.94

1.0

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

2.19

1.94

1.0

u/ml

0.6

0.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

504

1.39

1.94

5.1

4.6

u/ml

33.5

63.1

0.97

146

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

142

1.76

1.92

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

483

0.62

1.89

1.3

1.6

mmol/l

6.9

7.6

0.96

305

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

626

1.35

1.89

1.3

1.2

—

(40768800) Prostate Pathology biopsy report

590

0.66

1.86

1.1

1.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

374

1.45

1.86

2.2

2.1

nmol/l

16.8

19.0

1.18

352

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.03

1.85

3.3

2.8

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

248

2899

0.85

1.78

1.3

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1068

9954

1.09

1.78

5.0

4.8

ug/l

2.7

3.3

0.53

944

8900

(3044889) 12 lead EKG panel

3208

31153

1.07

1.74

4.9

3.6

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.50

1.73

1.0

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

178

1.63

1.72

1.6

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.85

1.71

5.0

4.8

umol/l

619.8

370.6

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

3.85

1.71

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.13

1.71

1.0

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.29

1.70

1.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

250

1.52

1.70

1.2

—

(3006462) Nitrate [Presence] in Urine

226

1.55

1.70

4.9

3.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

148

1.69

1.70

3.6

2.6

umol/l

24.7

29.2

1.12

103

(3027035) Albumin [Mass/time] in 24 hour Urine

2.38

1.67

1.2

1.3

—

640.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

124

1538

0.80

1.67

1.5

—

(3007916) DNA double strand Ab [Titer] in Serum

2.18

1.67

1.2

1.4

—

127.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

149

1.68

1.66

1.0

u/ml

11.3

4.4

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.58

1.65

2.0

2.2

—

(40761536) Microorganisms panel - Urine sediment

458

4105

1.13

1.65

6.7

3.7

—

(3005033) Fetal Nuchal fold Thickness US

167

1386

1.21

1.63

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

213

1.55

1.61

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.57

1.61

1.0

1.1

—

(44813793)

353

1.42

1.60

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

167

1390

1.21

1.59

1.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

397

1.39

1.56

1.1

mg/l

285.0

250.8

0.56

345

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

694

0.72

1.56

1.2

1.4

mmol/l

6.8

7.3

0.84

509

(3039443) Prostate specific Ag panel - Serum or Plasma

600

0.70

1.54

1.4

1.7

—

(3036048) Francisella tularensis Ab [Titer] in Serum

107

1.78

1.54

1.0

1.1

—

228.6

—

(40760409) HLA-A [Type] by High resolution

3.34

1.52

1.0

—

(46236302) HLA-C [Type] by High resolution typing

3.34

1.52

1.0

—

(3013862) HLA-DP [Type]

3.34

1.52

1.0

—

(40760410) HLA-B [Type] by High resolution

3.34

1.52

1.0

—

(40763590) HLA-DQ beta [Type]

3.34

1.52

1.0

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.34

1.52

1.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4569

45019

1.08

1.50

4.8

4.2

mmol/l

4.6

4.7

17.73

4170

41896

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

162

1.61

1.49

3.7

2.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.00

1.48

1.2

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1001

9381

1.08

1.47

1.5

—

(3045414) Leukocytes [Presence] in Urine

244

2115

1.16

1.47

2.1

1.9

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.73

1.43

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

110

1.73

1.42

1.0

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

103

1.75

1.40

1.2

1.1

—

(4024509)

466

1.33

1.40

2.0

1.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.18

1.39

3.5

2.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

313

1.41

1.38

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.08

1.38

1.0

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

1.80

1.37

1.3

1.5

g/l

25.3

26.4

0.08

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.80

1.37

1.0

1.1

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.61

1.36

1.0

8.8

8.1

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

2.61

1.36

1.0

36.1

36.9

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.94

1.36

1.4

nmol/l

556.1

520.7

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

223

1.48

1.35

1.4

1.3

77.8

69.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

135

1.63

1.35

2.0

1.4

ug/l

9.5

8.6

0.45

135

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.75

1.34

2.3

2.4

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.14

1.33

1.2

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.13

1.33

1.2

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

169

1438

1.18

1.31

1.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.84

1.29

2.0

1.3

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.35

1.29

1.0

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.78

1.28

1.2

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

2.78

1.28

1.6

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

252

1.43

1.25

1.8

1.9

ug/l

2.5

3.9

0.99

222

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4533

44725

1.07

1.25

4.8

4.1

mmol/l

1.5

1.59

4105

41392

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

107

1.68

1.25

1.1

1.4

31.3

34.8

0.18

(3025577) Chromium [Mass/volume] in Blood

244

1.44

1.25

1.8

2.0

ug/l

2.0

2.6

0.73

208

(4211845)

253

1.43

1.23

4.8

3.3

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.31

1.18

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.88

1.17

1.6

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

240

2119

1.14

1.17

1.6

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.00

1.16

1.0

1.1

umol/24h

1.6

1.7

—

(40768793) Breast Pathology biopsy report

144

1225

1.18

1.15

1.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

292

1.37

1.13

2.3

1.7

—

(4212803)

2.00

1.12

1.4

1.1

—

(3001556) Androgen free Index in Serum or Plasma

1.90

1.12

1.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

436

0.71

1.12

1.6

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

159

1.51

1.11

1.1

u/ml

4.4

1.9

0.24

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.26

1.10

1.0

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.26

1.10

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.38

1.09

17.6

10.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.95

1.08

5.0

2.7

u/field

1.3

0.7

—

(3016750) Collection duration of Urine

236

1.40

1.06

2.7

2.1

min

499.2

493.5

0.11

178

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.92

1.02

2.4

2.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

108

0.46

1.00

1.4

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

351

1.31

1.00

3.8

2.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.77

1.00

2.4

1.6

ng/l

108.7

109.2

0.01

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

2.00

1.00

1.0

1.1

u/l

—

5.0

—

(4027681)

317

1.33

0.99

1.3

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

317

1.33

0.99

1.1

ratio

1.1

1.0

0.10

107

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

249

1.37

0.97

1.2

1.4

pmol/l

36.3

179.3

0.72

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.63

0.97

1.1

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.80

0.96

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

311

1.32

0.94

7.3

6.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

321

1.31

0.92

1.1

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

2.14

0.91

1.0

1.3

u/ml

0.2

1.8

—

(3043410) Blood group antigens tested for on Red Blood Cells

134

1.49

0.91

1.8

1.7

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

144

1259

1.15

0.87

1.5

pmol/l

155.1

155.0

0.00

138

1232

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.58

0.87

1.1

1.2

ug/l

201.6

378.8

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

188

1.38

0.82

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.74

0.82

1.1

1.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.88

0.81

1.2

1.4

—

(40758292) HTLV I+II Ab panel - Serum

1.65

0.81

1.4

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

293

1.30

0.81

1.1

u/l

1.1

0.01

138

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

224

1.34

0.79

1.1

miu/ml

1646.0

1508.2

0.24

224

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.73

0.79

13.4

7.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

351

0.74

0.79

1.9

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

173

1.39

0.78

1.0

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.77

0.0

1.0

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.00

0.72

3.0

1.6

—

0.0

—

(3003338) MCHC [Mass/volume]

3928

39745

0.96

0.72

35.4

16.9

g/l

331.1

332.1

8.39

3899

39452

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.92

0.70

1.6

umol/24h

298.4

321.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

203

1.33

0.70

3.0

2.4

umol/l

63.7

53.5

0.69

163

(3036670) Protein [Mass/volume] in Synovial fluid

118

1.44

0.69

1.4

1.2

g/l

35.2

38.8

—

(40758358) Immune stain study

1.85

0.68

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.53

0.68

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

213

1.32

0.68

2.2

2.1

ug/min

33.0

143.8

—

(3019174) dRVVT (LA screen)

1.63

0.62

1.1

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

1.67

0.61

3.8

1.3

nmol/l

2.6

1.6

—

(3002619) Bacteria identified in Specimen by Culture

1.46

0.61

1.4

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

235

1.28

0.61

1.0

1.1

89.6

90.0

0.02

179

(3014051) Protein [Presence] in Urine by Test strip

1111

0.88

0.60

2.5

2.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.60

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.59

0.0

1.1

—

8.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.46

0.56

1.1

1.2

—

(4281824)

513

1.17

0.55

1.1

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

124

1.37

0.55

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.62

0.55

1.3

1.8

—

(3020650) Glucose [Presence] in Urine

125

1.36

0.53

1.2

1.5

—

(3004775) Volume in Urine collected for unspecified duration

313

1.22

0.53

2.7

2.2

715.2

617.9

0.78

210

(3051387) C reactive protein [Mass/volume] in Capillary blood

982

0.88

0.53

7.3

3.4

mg/l

29.3

26.2

0.33

597

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

110

1.36

0.48

1.7

3.1

ng/l

100.7

129.3

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.41

0.46

1.5

2.1

mmol/l

8.2

7.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

553

5757

0.96

0.45

2.9

3.0

ug/l

0.8

0.7

0.09

398

3773

(3028717) Thiamine [Mass/volume] in Blood

1.37

0.44

1.1

1.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.61

0.43

1.0

1.1

—

(3024263) Appearance of Synovial fluid

221

1.22

0.42

2.7

1.9

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.41

0.0

1.4

—

1.4

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

357

0.84

0.39

1.3

1.4

nmol/l

24.1

32.5

1.68

318

(3022670) pH of Venous cord blood

0.00

0.39

0.0

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

1.39

0.38

1.0

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.39

0.38

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.39

0.38

1.0

—

(4133840)

114

0.70

0.37

1.3

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

152

1.25

0.37

1.2

1.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

152

1.25

0.37

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

212

0.80

0.35

1.4

1.3

—

(44806420)

108

1.30

0.35

2.4

2.3

—

(3002385) Erythrocyte distribution width [Ratio]

3864

38908

0.98

0.34

32.2

16.0

14.0

13.6

25.81

3804

38072

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.33

0.33

1.0

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

393

0.86

0.33

1.0

1.1

—

(3014891) Appearance of Pleural fluid

1.30

0.30

1.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.27

0.30

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

268

2794

0.96

0.28

1.8

1.7

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.29

0.28

1.4

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

0.70

0.26

10.0

6.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

225

1.16

0.26

1.6

2.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.17

0.24

3.4

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.17

0.24

6.9

6.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

333

3222

1.04

0.24

1.5

—

(3022689) Creatine [Moles/volume] in Urine

124

1.21

0.23

2.3

1.5

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.32

0.23

1.8

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

162

1.17

0.22

2.9

3.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

811

7960

1.02

0.22

4.4

4.2

20.9

21.8

0.91

368

3778

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.22

0.22

1.6

1.1

u/l

6.2

17.7

—

(3036071) Salmonella sp Ab [Titer] in Serum

163

1.17

0.21

1.1

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.21

0.0

1.2

—

71.1

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

16.8

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.21

0.0

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.22

0.21

1.9

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

392

1.10

0.21

2.7

3.0

mg/l

56.8

34.2

0.36

291

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.21

0.18

1.0

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

1.17

0.17

1.3

1.4

ug/l

92.9

121.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.15

0.17

1.1

1.4

—

(3000330) Specific gravity of Urine by Test strip

232

2250

1.03

0.17

5.3

3.4

—

(3022621) pH of Urine by Test strip

301

3088

0.97

0.16

4.4

2.9

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

738

1.06

0.16

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

173

1671

1.04

0.16

1.7

1.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

847

1.05

0.16

1.8

1.7

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

284

0.92

0.13

1.0

ng/l

47.3

45.2

0.11

183

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

191

1963

0.97

0.13

1.5

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

282

0.92

0.12

1.0

ng/l

786.1

710.4

0.39

183

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

280

0.93

0.10

1.0

ng/l

324.9

334.0

0.09

184

(44806071)

1.08

0.08

1.0

1.1

—

(4094501)

111

1131

0.98

0.05

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

262

0.95

0.04

1.1

—

(3015183) Erythrocyte sedimentation rate

258

1.05

0.04

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

129

1.01

0.00

1.2

1.4

—

(3000012) Reticulocyte production index

206

1.02

0.00

1.5

1.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.00

0.00

1.4

2.1

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.2

—

33.2

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1150.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

37.2

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

7.8

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

118.6

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.88

0.00

11.6

9.8

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.95

0.00

1.4

1.3

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.0

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.94

0.00

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

90.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.89

0.00

1.9

1.6

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_CANDIDIASIS and mortality.

Females

Parameter	HR [95% CI]	p-value
AB1_CANDIDIASIS	2.209 [1.96, 2.49]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.243

During the follow-up period (1.1.1998 — 31.12.2019), 3272 out of 18717 females with AB1_CANDIDIASIS died.

Males

Parameter	HR [95% CI]	p-value
AB1_CANDIDIASIS	2.783 [2.44, 3.17]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.028

During the follow-up period (1.1.1998 — 31.12.2019), 2863 out of 9856 males with AB1_CANDIDIASIS died.

Mortality risk

Mortality risk for people of age

years, who have AB1_CANDIDIASIS.

N-year risk	Females	Males
1	0.173%	0.462%
5	1.476%	3.097%
10	3.09%	8.088%
15	6.23%	15.566%
20	11.174%	25.078%

Relationships between endpoints

↥

Index endpoint: AB1_CANDIDIASIS – Candidiasis

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Candidiasis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints